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ABSTRACT 
 
DANIEL BROWN: Elucidating the Roles of the Cardiogenic Factors Tbx20, Tbx5 and 
Hsp27 in Vertebrate Heart Development 
(Under the direction of Frank Conlon) 
 
 
 The development of a functional multi-chambered contractile heart from a simple 
patterned tube involves a number of interacting transcriptional networks acting within 
well-defined temporal and spatial parameters.  While many of the regulatory transcription 
factors have been identified and shown to be required for proper cardiogenesis, much 
remains to be deciphered regarding how these pathways interact at different times and 
within different cell populations during cardiogenesis.  In addition, very little is currently 
known as to the specific downstream pathways affected by the various transcriptional 
regulators known to be involved in cardiac morphogenesis.  
 In this dissertation, I describe the identification of several novel Xenopus laevis 
(X. laevis) genes expressed during heart development, including T-box 20 (Tbx20), titin 
novex 3 (XTn3), and heat shock protein 27 (XHsp27), thus providing evidence that these 
genes may be involved in cardiogenesis. By depleting X. laevis embryos of TBX20 and 
the related T-box protein, TBX5, I demonstrate that these proteins are both critical for 
proper cardiac morphogenesis. In addition, I provide evidence for a physical and 
functional interaction between TBX20 and TBX5 in cardiogenesis, thus adding one 
potential point at which multiple pathways may converge during heart development. 
Results from a microarray-based screen I conducted to identify genes downstream of 
 ii
Tbx5 function led to the identification of several cell cycle genes putatively misregulated 
in response to loss of TBX5. This work led directly to a study conducted by Sarah Goetz 
in which she has demonstrated a requirement for Tbx5 for proper cell cycle progression, 
thus further elucidating downstream pathways in heart development. A similar screen I 
performed to identify genes misregulated in response to loss of Tbx20 yielded a host of 
novel cardiac-specific genes, setting up the basis for future studies to come. This 
microarray experiment further resulted in the identification of Hsp27, which I 
subsequently demonstrated is required for proper fusion of cardiac precursors and for 
actin cytoskeleton integrity. Thus, this dissertation significantly advances our 
understanding of cardiogenesis at multiple levels, including the identification of factors 
involved in cardiogenesis, interactions between these factors, and downstream cellular 
behaviors affected by these factors. 
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CHAPTER I 
GENERAL INTRODUCTION 
 Of the many known congenital diseases that affect human beings, those affecting 
development of the heart are among the most severe. A functioning cardiovascular system is 
integral to nearly every process and system that makes human existence possible.  
Development of the heart is an incredibly complex process requiring the coordination of 
many events within well-defined spatial and temporal dimensions (reviewed in Harvey, 
2002). The complex nature and multitude of coordinated steps within cardiogenesis make 
this process inherently sensitive to genetic perturbation. As such, it is not surprising that 
congenital heart disease is the most common cause of prenatal mortality (Hoffman, 1995a; 
Hoffman, 1995b; Kochanek et al., 2004), and is estimated to be responsible for 10% to 15% 
of all maternal mortalities during childbirth (Gei and Hankins, 2001; Klein and Galan, 2004). 
Furthermore, current data from the Centers for Disease Control estimates that one out of 
every one hundred and ten babies born in the United States is afflicted with a congenital heart 
disease (Thom et al., 2006). In addition to the problems associated with congenital heart 
diseases, a number of adult heart diseases are highly prevalent, including myocardial 
infarction and hypertrophy. Research has shown that many of these diseases are 
characterized by a recapitulation of cardiogenic processes and transcriptional programs in the 
cardiac tissue. For instance, ventricular hypertrophy has been shown to involve upregulation 
of several of the earliest expressed cardiac transcription factors including Gata4, Nkx2.5, 
  
Mef2, eHand and dHand (Bar et al., 2003). Thus, understanding the cellular, molecular, and 
genetic events involved in the creation of a heart remains one of the biggest and potentially 
highest impacting challenges facing human health today. 
 
A.  Mechanisms of Heart Induction and Development 
Cardiac Progenitor Induction 
 The vertebrate heart is a highly complex muscular pump necessary for the 
dissemination of nutrition and signaling molecules and for the exchange of gases throughout 
the body. It also functions to transport wastes away from their tissues of origin to the systems 
that remove them.  In mammals and avians, the heart consists of two separate but fused 
pumps, each containing one atria and one ventricle, which service the pulmonary and 
systemic systems of the body, respectively (reviewed in Olson, 2006). In contrast, amphibian 
and reptile hearts contain two atria and one ventricle all serving as a single pump, although 
the ventricle is partially divided in reptiles (reviewed in Olson, 2006). In these organisms, 
blood flows from the heart, through the pulmonary system, and then to the rest of the body 
(reviewed in Olson, 2006). Further down on the evolutionary ladder, fish hearts consist of 
one atria and one ventricle and do not have pulmonary circulation (reviewed in Olson, 2006). 
Despite the differences in chamber number and organization between various vertebrate 
lineages, early heart development occurs in a nearly identical fashion mechanistically 
between these organisms (Chen and Fishman, 2000; DeRuiter et al., 1992; Keller, 1976; Lohr 
and Yost, 2000; Sater and Jacobson, 1989; Stainier et al., 1993).  
 During gastrulation, when the three germ layers, endoderm, ectoderm and mesoderm, 
are formed, a bilaterally symmetric pair of cell fields within the mesoderm are specified to 
 2
eventually give rise to the heart.  However, before this specification can occur, the 
mesodermal germ layer must first form through an inductive interaction with the endoderm 
(reviewed in Harland and Gerhart, 1997). Mesoderm induction is followed by a refinement in 
mesodermal character (e.g. ventral mesoderm versus dorsal mesoderm) via signals emanating 
from a region in X. laevis termed the “Spemann Organizer”. The Spemann Organizer, a 
region of the embryo that shares some similarity to the node in avians and mammals, secretes 
a host of signaling molecules that function by inhibiting the Wnt and bone morphogenetic 
protein (BMP) signals emanating from the ventral region of the embryo (Fig. 1.1A). The 
canonical Wnt pathway involves the binding of Wnt ligands to their Frizzled and LRP family 
receptors and transduction of signaling to β-catenin, which translocates into the nucleus and 
forms a complex with TCF transcription factors resulting in activation of Wnt target genes 
(for a review of the Wnt pathway see Gordon and Nusse, 2006). BMPs are members of the 
transforming growth factor β (TGFβ) family of proteins and function by binding Type I and 
Type II receptors, resulting in the binding of receptor SMAD with a co-SMAD and activation 
of BMP target genes (for a review of the BMP pathway see Nohe et al., 2004). The interplay 
between Wnt/Bmp signaling from the ventral region of the embryo and Wnt/BMP 
antagonism by the Spemann organizer results in the formation of ventral mesoderm in 
regions of high Wnt/Bmp signaling and dorsal mesoderm in regions of low Wnt/Bmp 
signaling.  
 Once the dorsal mesoderm is induced, the local environment within the lateral 
mesoderm becomes permissive for cardiac specification. Studies have shown that at least two 
independent signaling events must occur for the cardiac progenitors to be specified.  First, 
during gastrulation the dorsal organizer secretes the inhibitors of canonical Wnt signaling, 
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Dikkopf 1 (Dkk1) and crescent, and these events are critical for cardiac induction (Marvin et 
al., 2001; Schneider and Mercola, 2001). Recent work by Foley and Mercola (2005) has 
demonstrated that canonical Wnt inhibition by Dkk1 leads to cell-autonomous expression of 
the homeobox transcription factor Hex (Foley and Mercola, 2005). They further show that 
the repressive activity of Hex is required for the production of an unknown signal resulting in 
cardiac induction, thus demonstrating a non cell-autonomous requirement for Hex in 
cardiogenesis (Foley and Mercola, 2005). Other studies have also implicated Nodal signaling 
in cardiogenesis and Hex regulation, although the specific role of Nodal in heart development 
is currently unclear (Griffin and Kimelman, 2002; Ladd et al., 1998; Logan and Mohun, 
1993; Sugi and Lough, 1994; Yatskievych et al., 1997; Yatskievych et al., 1999). In addition 
to the requirement for Wnt antagonism from the organizer, it is also well-known that a signal 
emanating from the endoderm adjacent to the cardiac progenitor region is also necessary for 
proper cardiac induction (Nascone and Mercola, 1996). This requirement is at least partially 
due to the secretion of BMPs from the adjacent anterior endoderm. Head mesoderm is 
induced by the dorsal organizer and requires antagonism of BMP and Wnt signals emanating 
from the ventral region of the embryo (Niehrs et al., 2001; Perea-Gomez et al., 2001). This is 
accomplished by the secretion of the Wnt inhibitors Dkk1 and crescent, and the BMP 
inhibitors chordin and noggin, among others (Niehrs et al., 2001; Perea-Gomez et al., 2001). 
In contrast, the cardiac precursors are induced at the lateral edges of the head precursor zone, 
where Wnt signaling is efficiently inhibited by Dkk1 and crescent but BMP signals are still 
present (Fig. 1.1A; Marvin et al., 2001; Schneider and Mercola, 2001). Several studies have 
demonstrated a critical requirement for BMPs in proper cardiac specification (Andree et al., 
1998; Ladd et al., 1998; Schlange et al., 2000; Schultheiss et al., 1997; Shi et al., 2000; 
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Zhang and Bradley, 1996). In addition, several SMAD proteins, which are downstream 
effectors of BMP signaling, can directly activate Nkx2.5, an early cardiac transcription factor 
(see below; Liberatore et al., 2002; Lien et al., 2002; Schwartz and Olson, 1999; Sparrow et 
al., 2000). Consistent with the hypothesis that Dkk1 and Wnt inhibition is required for 
cardiac induction, the Wnt inhibitors Dkk1 and members of the Frizzled-like family of 
proteins are expressed in the anterior endoderm as well as in the aforementioned organizer 
(Marvin et al., 2001; Schneider and Mercola, 2001). These data combined suggest that 
interplay between Wnt antagonism and BMP signaling from the organizer and anterior 
endoderm is partially responsible for cardiac induction. In corroboration of this hypothesis, 
experiments have shown that non-cardiogenic posterior mesoderm can be induced to form 
cardiac mesoderm in the presence of both BMP signals and Wnt antagonists (Marvin et al., 
2001; Schneider and Mercola, 2001; Tzahor and Lassar, 2001). Furthermore, in X. laevis this 
dual presence can lead to the formation of contractile cardiac tissue lined with an 
endothelium in the posterior non-cardiogenic mesoderm when induced ectopically 
(Schneider and Mercola, 2001).  
 In addition to the requirement for BMP signaling and Wnt antagonism in heart 
induction, a role for several other signaling pathways has also been implicated. Fibroblast 
growth factor 8 (Fgf8), which is also expressed in the endoderm, can be induced by BMP 
signaling and is required for cardiac specification (Alsan and Schultheiss, 2002).  
Furthermore, mice lacking the Hedgehog receptor Smoothened (Smo) fail to initiate Nkx2.5 
expression (Zhang et al., 2001).  Thus considering that the Smo ligand Indian Hedgehog 
(IHH) is expressed in the endoderm and can induce BMP4 expression, these data suggest that 
Hedgehog signaling is also an important regulator of cardiogenesis (Zhang et al., 2001). In 
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summary, many different signaling cascades originating from the surrounding tissues are 
involved in commitment to the cardiac lineage, including Wnt antagonists, BMPs, FGF8, and 
Hedgehog signals. 
 
Cardiac Progenitor Migration and Fusion 
 Once the cardiac precursor fields are specified they undergo two separate migration 
events as neurulation proceeds (reviewed in Harvey, 2002).  The large-scale tissue 
movements involved in gastrulation and subsequent convergent extension result in the 
anterior migration of the cardiac progenitors toward more anterior regions (Fig. 1.1B). This 
process seems to be largely controlled by FGF factors such as FGF8 and FGF4 (Beiman et 
al., 1996; Ciruna and Rossant, 1999; Gisselbrecht et al., 1996; Sun et al., 1999).  The 
progenitors then migrate ventrally towards the anterior ventral midline (Figs. 1.1C, 1.2; 
DeHaan, 1963).  Expression of fibronectin (Fn) at the junction between the endoderm and 
mesoderm appears to be required for this migration; mutant mice lacking Fn exhibit cardia 
bifida, which is characterized by unfused cardiac progenitors that independently differentiate 
into cardiac tissue (George et al., 1997). It has also been well established that the anterior 
endoderm is required for cardiac progenitor migration. For example, many genes involved in 
endoderm differentiation and maturation result in cardia bifida when mutated in mice or fish, 
and it is currently thought that the cardiac defects result from a loss of cardiac migration 
factors from mature endoderm, such as the aforementioned Fn (Crispino et al., 2001; 
Kupperman et al., 2000; Reiter et al., 1999; Stainier, 2001).  
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Linear Heart Tube Formation and Cardiac Looping 
 Once the presumptive cardiac mesoderm meets at the ventral midline, the two pre-
cardiac fields fuse resulting in a single contiguous sheet of mesoderm at the anterior ventral 
midline (Fig. 1.2; for reviews of this process see Fishman and Chien, 1997; Harvey, 2002) 
and (Mohun et al., 2003).  Dorsal to this mesoderm lays the anterior endoderm, which will 
eventually form the pharynx, liver, and gut. At this stage, the pre-cardiac mesoderm appears 
morphologically as a wedge-shaped trough in X. laevis (Fig. 1.2) or as a crescent in avians 
and mammals. Shortly after progenitor fusion at the midline, the lateral edges of the 
cardiogenic field roll dorsally and medially to form a linear heart tube (Fig. 1.2). The dorsal-
most aspect of this tube remains connected to the surrounding lateral mesoderm by way of a 
thin strip of dorsal mesocardial tissue. As the linear heart tube forms, the surrounding space 
expands to form the pericardial cavity. While the cardiac field is still in trough form, a layer 
of endothelial tissue is already evident just dorsal to the layer of myocardial precursors (Fig. 
1.2; Stainier et al., 1993). This endothelial tissue is encompassed by the developing heart 
tube to eventually form the endocardium. Evidence from lineage tracing experiments 
suggests that the endocardium is also mesodermally-derived; however it is currently 
unknown whether this mesoderm is the sole ancestor of the endocardium (Fig. 1.2; Raffin et 
al., 2000). 
 Once the linear heart tube forms, a further morphogenetic event is necessary to 
properly position the presumptive atrial and ventricular regions: cardiac looping 
morphogenesis (Fig. 1.3; for reviews of looping morphogenesis see Fishman and Chien, 
1997; Harvey, 2002; Mohun, 2000). The general structure of the heart in all adult vertebrates 
consists of the atrium (or atria) in the dorsal anterior position and the ventricle (or ventricles) 
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just ventral and posterior to the atria (Fig. 1.3; DeHaan and Ursprung, 1965). However, in the 
linear heart tube phase, the relative positions of the future atria and ventricle are precisely 
opposite of their positions in the adult heart. Initially, the most anterior portion of the heart 
tube consists of the future ventricle and outflow tract. Conversely the posterior portion 
consists of the future inflow tract and atria. As development proceeds, the tube undergoes 
spiral looping whereby the inflow region initially moves leftward, in a process termed 
“leftward jogging”. The future atria then move dorsally and anteriorly, repositioning itself 
just dorsal and anterior to the future ventricle (Fig. 1.3).  At this stage in cardiogenesis, 
differences in myocardial wall thickness become evident as atrial and ventricular chamber 
identities develop (Bisaha and Bader, 1991; Christoffels et al., 2000; Edmondson et al., 1994; 
Mohun, 2000). The primitive heart begins to undergo many processes of chamber formation 
and remodeling, including septation of the atria, formation of valves and endocardial 
cushions, and trabeculation of the ventricle (reviewed in Fishman and Chien, 1997). These 
processes result in the formation of a mature tadpole heart consisting of two small thin-
walled atria and a single thick-walled ventricle (Fig. 1.3). 
 
B. Molecular Control of Heart Development 
 As discussed above, induction of cardiac progenitors requires the interaction of 
multiple tissues and several signaling pathways, including BMPs, non-canonical Wnts, 
canonical Wnt inhibitors, and FGFs. These signaling events result in the initiation of many 
distinct programs of cardiac differentiation leading to many different cardiac cell types 
reviewed in (Bruneau, 2002; Eisenberg and Markwald, 2004; Fishman and Chien, 1997; 
Olson, 2006). It is becoming increasingly clear that a complex molecular regulatory network 
is required in the specification, differentiation, and morphogenesis of a functional heart.  The 
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proteins implicated in controlling these processes include a number of transcription factors 
from a range of transcription factor families, including the T-box, basic helix-loop-helix 
homeobox, GATA, zinc finger, and MADS domain families (Cripps and Olson, 2002; 
Harvey, 2002; Zaffran and Frasch, 2002). Specific transcription factors thus far identified as 
critical for proper cardiogenesis include Nkx2.5, myocardin, Gata4-6, SRF, Tbx5, Tbx20, and 
many others. In this introduction I focus on Nkx2.5, Gata4-6, Tbx20, and Tbx5, due to the 
direct relevance of these factors to the work presented herein. 
 The homeobox transcription factor Nkx2.5 is one of the earliest markers of the cardiac 
precursors. Nkx2.5, which was initially identified as critical for Drosophila dorsal vessel 
formation, has been demonstrated to be essential for establishment and maintenance of 
ventricular gene expression and differentiation (Bodmer, 1993; Bruneau et al., 2000; Lyons, 
1995; Tanaka et al., 1999).  Furthermore, mice lacking Nkx2.5 display reduced myocardial 
growth and a failure of cardiac looping morphogenesis (Lyons, 1995). Expression of Nkx2.5 
has been shown to be largely controlled by the downstream effectors of BMP signaling, 
SMADs, as well as by GATA factors (Lee et al., 2004; Lien et al., 1999; Schlange et al., 
2000; Searcy et al., 1998). Furthermore, dominant-negative experiments in X. laevis have 
suggested that expression of the cardiac transcription factor myocardin, which interacts with 
serum response factor (SRF) to control transcription, is necessary for high-level Nkx2.5 
expression and cardiac differentiation (Wang et al., 2001). 
 In addition to the requirement for Nkx2.5 in cardiac specification and differentiation, 
three GATA family members have also been demonstrated as critical for cardiogenesis: 
gata4, gata5, and gata6. As mentioned above, gata4 and gata5 are known to be important for 
proper endoderm maturation and thus important for proper interaction between endoderm 
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and mesoderm in cardiac formation.  However, studies have also demonstrated a role for 
GATA factors within developing cardiac tissue. Studies in P19 embryonal carcinoma cells 
have shown that induced cardiac differentiation is arrested when gata4 or gata6 is removed 
by antisense oligonucleotides (Grepin et al., 1995; Narita et al., 1997).  Furthermore, a role 
for GATA factors in cardiogenesis appears to have been conserved throughout evolution, as 
flies mutant for the Drosophila homologue of gata4, pannier, display defects in cardiac 
progenitor proliferation (Gajewski et al., 1999). 
  
 
T-box Genes in Cardiogenesis 
 In addition to the aforementioned families of cardiogenic transcription factors, 
members of another class of transcription factors have been shown to be integral regulators 
of vertebrate cardiogenesis: the T-box proteins. The T-box family of transcription factors is a 
large family of proteins involved in determining early cell fate decisions, such as those 
necessary for formation of the basic vertebrate body plan, as well as for controlling 
differentiation and organogenesis (reviewed in Naiche et al., 2005; Showell et al., 2004). The 
involvement of T-box genes in these processes is emphasized by the observation that 
mutation of many T-box members results in dramatic phenotypes in mouse and zebrafish 
(Beddington et al., 1992; Bruneau et al., 2001; Chapman et al., 1996a; Fujimoto et al., 1991; 
Garrity et al., 2002; Schier et al., 1997; Schulte-Merker et al., 1994). Furthermore, alterations 
in T-box gene expression or function have been shown in a number of human congenital 
malformations and are amplified in a subset of cancers (reviewed in Papaioannou, 2001; 
Smith, 1999; Wilson and Conlon, 2002). The T-box family has recently been shown to 
comprise approximately 0.1 % of genomes as diverse as C. elegans and human and have 
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been identified in a wide variety of chordates from ctenophores to humans while being 
completely absent in genomes from other phyla (e.g. Arabidopsis thaliana). For many of 
these genes clear homologues exist, such as Brachyury, which displays a high degree of 
conservation in sequence, expression pattern, and function between a variety of vertebrates 
including fish, frog, dog and mouse (Haworth et al., 2001; Herrmann and Lehrach, 1988; 
Schulte-Merker et al., 1994; Smith et al., 1991). However, other T-box genes appear to be 
unique to particular species. For instance, VegT, a T-box gene thought to be required for 
endoderm formation in Xenopus, has no apparent homologue or orthologue in mouse or 
human (reviewed in Wilson and Conlon, 2002).  
 Two sets of clinical studies have provided direct evidence for a role for T-box genes 
in human heart development and differentiation. Patients with DiGeorge syndrome, a disease 
characterized by cardiac outflow tract defects as well as defects in other neural-crest-derived 
structures, are often deleted for the T-box gene Tbx1 (Baldini, 2004; Chieffo et al., 1997; 
Jerome and Papaioannou, 2001; Lindsey et al., 2001; Merscher et al., 2001; Yagi et al., 
2003). Furthermore, a second congenital heart disease, Holt-Oram Syndrome, has been 
shown to be associated with mutations in the coding region of another T-box family member, 
Tbx5 (Basson et al., 1997; Li et al., 1997). In addition to Tbx1 and Tbx5, recent studies in 
Xenopus, human, mouse, chick and zebrafish have implicated a third member of the T-box 
gene family, Tbx20, in heart development (Brown et al., 2005; Cai et al., 2005; Carson et al., 
2000; Griffin et al., 2000; Iio et al., 2001; Kraus et al., 2001; Meins et al., 2000; Stennard et 
al., 2005; Szeto et al., 2002; Takeuchi et al., 2005).  
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Tbx20 
 Tbx20 was initially identified by Meins and colleagues (2000) by searching the 
human genome for sequences homologous to the Drosophila T-box gene H15 (Meins et al., 
2000). This study resulted in the identification of both human and mouse orthologues of 
Tbx20, and demonstrated enrichment of Tbx20 expression in heart tissues. Shortly thereafter, 
apparent orthologues of Tbx20 were identified in chick and zebrafish, and shown to be 
expressed within the developing heart (Griffin et al., 2000; Iio et al., 2001). In all species 
examined, Tbx20 expression begins in the anterior lateral plate mesoderm and gradually 
becomes restricted to the Nkx2-5-expressing cardiac primordia prior to ventral migration and 
convergence at the midline.  This expression continues in the heart throughout the processes 
of migration, jogging, looping, and cardiac chamber formation. Thus, Tbx20 is expressed at 
the same time as and in many regions of the heart that also express the heart markers Tbx5, 
Nkx2-5, and Gata4 (Horb and Thomsen, 1999; Serbedzija et al., 1998; Tonissen et al., 1994). 
Furthermore, I here report that Tbx20 expression in the developing heart throughout the 
entire course of cardiogenesis is conserved in X. laevis (see Chapter II; Brown et al., 2003). 
Despite our knowledge of the expression pattern of Tbx20 in several vertebrates, little 
was known of Tbx20 function in heart development prior to the experiments reported in this 
dissertation work. In the zebrafish, it has recently been observed that eliminating endogenous 
TBX20 (HRT) via morpholinos leads to cardiac defects (Szeto et al., 2002).  Specifically, 
TBX20 knockdown in zebrafish leads to dysmorphic hearts and a loss of blood circulation 
(Horb and Thomsen, 1999; Szeto et al., 2002).  The morphological defects are not apparent 
until cardiac looping stage, despite high levels of Tbx20 during the earlier stages of 
specification and development, suggesting that other T-box genes may act redundantly with 
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Tbx20 during early heart development.  In this dissertation I further demonstrate by TBX20 
depletion using antisense morpholinos that TBX20 is critical for proper cardiac growth and 
morphogenesis in X. laevis (see Chapter III; Brown et al., 2003; Brown et al., 2005). In 
addition, I show that TBX20 can physically and functionally interact with TBX5, and that the 
neither factor is required for expression of the other. Subsequent to my thesis work, several 
studies concurrently reported that mutation of Tbx20 in mice results in cardiac defects (Cai et 
al., 2005; Stennard et al., 2005; Takeuchi et al., 2005). Findings from these studies 
corroborate the work reported herein, demonstrating that loss of TBX20 function results in 
reduced cardiac growth and failure of cardiac looping morphogenesis. Studies from the 
mouse Tbx20 mutants further reveal that one role of TBX20 appears to be to repress 
expression of Tbx2, which itself can repress expression of Nmyc1, a regulator of cellular 
proliferation (Cai et al., 2005; Stennard et al., 2005). These results suggest a model in which 
loss of TBX20 results in overexpression of Tbx2, repression of Nmyc1, and thus repression of 
cellular proliferation. Furthermore, a role for Tbx20 function in cardiogenesis appears to be 
ancient in evolutionary origin, as recent studies have demonstrated that the Drosophila 
orthologues of Tbx20, H15 and midline, are also required for proper development of the 
dorsal vessel, which is thought to be homologous to the vertebrate heart (Miskolczi-
McCallum et al., 2005; Reim et al., 2005). 
 
Tbx5 
 Along with Nkx2.5 and Tbx20, Tbx5 is among the first genes expressed in cardiogenic 
precursor cells (Griffin et al., 2000; Horb and Thomsen, 1999; Tonissen et al., 1994).  During 
vertebrate cardiogenesis, Tbx5 is expressed throughout the heart in a graded fashion, 
 13
excluding the outflow tract.  As mentioned above, clinical studies of Holt-Oram Syndrome 
(HOS) patients have demonstrated a fundamental role for Tbx5 in heart development. HOS is 
a highly penetrant autosomal-dominant condition associated with a host of skeletal and 
cardiac malformations, including defects in upper limb development, atrial and ventricular 
septal defects, and deficits in cardiac conduction (Newbury-Ecob et al., 1996). Patients with 
HOS often carry mutations within the coding region of Tbx5 (Basson et al., 1997; Basson et 
al., 1999; Benson et al., 1996; Li et al., 1997). Furthermore, Tbx5 has been shown to be 
essential for proper heart morphogenesis in several vertebrate species. Studies on mice and 
zebrafish mutated for Tbx5, dominant negative studies in X. laevis, and antisense morpholino 
experiments in zebrafish have demonstrated a requirement for Tbx5 in proper cardiac looping 
and morphogenesis (Bruneau et al., 2001; Garrity et al., 2002; Horb and Thomsen, 1999).  In 
mice, despite the early expression of Tbx5 in the presumptive cardiogenic mesoderm, Tbx5 
appears to be dispensable for cardiac crescent or heart tube formation, but is instead required 
for growth and differentiation of the left ventricle and atria. Tbx5 null mice arrest in 
development at E9.5, and display severely hypoplastic hearts, conduction defects, as well as 
gross aberrations in cardiac morphology, including an absence of looping. Tbx5 heterozygous 
mice display atrial and ventricular septal defects and cardiomegaly, demonstrating that 
precise Tbx5 dosage is important for proper heart development (Bruneau et al., 2001). 
Coincident with these morphological defects, atrial natriuretic factor (ANF) and connexin 40 
(cx40) expression is diminished or absent (Bruneau et al., 2001). Studies in X. laevis have 
shown that when Tbx5 function is inhibited by dominant-negative hormone-inducible TBX5, 
the heart is grossly abnormal and reduced in size or absent (Horb and Thomsen, 1999). 
Furthermore, myosin light chain 2 (MLC2), Nkx2-5, and endogenous Tbx5 levels are reduced 
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in embryos injected with the dominant negative Tbx5 (Horb and Thomsen, 1999). These 
studies demonstrate that mice heterozygous for mutations in Tbx5 display many of the 
phenotypic abnormalities of HOS patients, and show that TBX5 is required for growth and 
differentiation of the left ventricle and atria as well as for proper development of the cardiac 
conduction system. Expression of Tbx5 has also been shown to increase differentiation of 
P19C16 cells, further suggesting a role for Tbx5 in cardiac differentiation. Similar results are 
seen in the zebrafish Tbx5 mutation, heartstrings, characterized by a lack of cardiac looping 
and subsequent degeneration of both the atrium and ventricle, suggesting that the expression 
and function of TBX5 is conserved throughout vertebrate evolution (Garrity et al., 2002). 
 
Potential Interactions Between Tbx5 and Tbx20 
Tbx20 expression is observed in a graded pattern with the highest levels being 
expressed caudally (Carson et al., 2000; Stennard et al., 2003).  This is very similar to the 
pattern of Tbx5 expression, which also lies in a caudal-high gradient along the long axis of 
the heart (Bruneau et al., 1999).  Furthermore, the temporal onset of Tbx5 expression occurs 
near the same time as that of Tbx20 (2 hours earlier in zebrafish; (Griffin et al., 2000). Thus, 
both Tbx5 and Tbx20 are expressed throughout cardiogenesis in overlapping domains. 
However, while Tbx20 and Tbx5 share overlapping domains of expression within the 
developing heart, there are some differences in their expression.  Of note is the fact that the 
outflow tract is a site of major Tbx20 expression, in contrast to Tbx5, which is not 
significantly expressed in the outflow tract, while Tbx5 and not Tbx20 is expressed in the 
common cardinal and hepatic veins. Nonetheless, the similarity in expression domains and 
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homology within the DNA-binding domain of Tbx20 and Tbx5 suggest that perhaps the two 
genes cooperate to regulate cardiogenesis. 
In addition to expression evidence suggesting the possibility of an interaction 
occurring between Tbx20 and Tbx5, data on the physical interactions of TBX20 and TBX5 
also indicate such a possibility.  For instance, both TBX20 and TBX5 have been shown to 
physically interact with NKX2-5 and GATA4 to synergistically activate transcription of 
target genes (Bruneau et al., 2001; Garg et al., 2003; Stennard et al., 2003).  Furthermore, the 
mesodermal T-box gene brachyury has been shown to bind DNA as a homodimers (Muller 
and Herrmann, 1997). Recent studies have also reported homodimerization of another T-
domain protein, TBX1, which is associated with the congenital heart disease DiGeorge 
Syndrome (Sinha et al., 2000). Thus, considering that both TBX5 and TBX20 share 
interacting partners and are both present in overlapping domains, combined with evidence 
that T-box proteins can at least homodimerize, it seems highly possible that TBX20 and 
TBX5 may physically interact with one another to heterodimerize or exist within the same 
complex to control cardiogenesis. 
 
Titin Novex-3 
 As described above, formation of a functioning heart requires the activity of many 
transcription factors that act by regulating target gene expression. The end goal of this 
complex regulatory network is the formation of contractile muscle tissue. Muscles are 
composed of myofibers, which are in turn made of bundles of smaller myofibrils. Thus, 
differentiation of cardiomyocytes results in the production of various structural proteins that 
can assemble to form individual myofibrils. Contractile myofibrils consist of an organized 
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structure of thin actin-based filaments and thick myosin-based filaments held in place by 
filaments composed of another structural protein termed “Titin”. The giant muscle protein 
titin is the largest known protein in the biological world and the single human titin gene 
contains 363 exons with a coding potential of 38,138 amino acids. Many splice-variants of 
titin have been described and full-length isoforms have been shown to span half the 
sarcomere length from the Z-line to the M-line, serving to link the two regions and stabilize 
sarcomere length by acting as a molecular spring (reviewed in Granzier et al., 2002). To date, 
the cloning or expression of Xenopus titin orthologues has not been reported. Recently a 
novel human titin exon, termed novex-3, was identified within the human titin locus and 
shown to encode an alternative C-terminal exon resulting in a truncated titin isoform that is 
too short to reach the A-band (Bang et al., 2001).  This isoform was shown to be expressed in 
human skeletal and cardiac muscle (Bang et al., 2001). In this dissertation, I report the 
identification of a X. laevis orthologue of titin novex 3 (XTn3) and demonstrate that XTn3 
expression is developmentally regulated during cardiac and skeletal myogenesis. These data 
suggest a potential role for XTn3 in muscle differentiation. 
 
Hsp27 
 As described above, ventral migration and fusion of the cardiac fields require the 
coordination of many processes, including proper cardiomyocyte differentiation (Reiter et al., 
1999; Yelon et al., 2000), signaling from the endoderm (Alexander et al., 1999; Kikuchi et 
al., 2000; Reiter et al., 1999; Schier et al., 1997), epithelial organization of the cardiac fields, 
and migration cues from the midline (Trinh and Stainier, 2004). Studies have implicated 
many molecules as being required for proper cardiac fusion, such as the extracellular matrix 
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protein fibronectin (Fn), which has been demonstrated to be necessary for proper epithelial 
integrity and migration of the cardiac progenitors (Trinh and Stainier, 2004). It has also been 
established that the anterior endoderm is required for cardiac progenitor migration (reviewed 
in (Lough and Sugi, 2000). For example, mutation of many genes involved in endoderm 
differentiation and maturation, including Gata4, Gata5, one-eyed pinhead (oep), casanova, 
and miles apart result in cardia bifida (Kuo et al., 1997; Kupperman et al., 2000; Reiter et al., 
1999; Stainier, 2001). Furthermore, studies have shown that proper myocardial 
differentiation is integral to the cardiac fusion process (Reiter et al., 1999; Yelon et al., 
2000). In this dissertation I report an additional requirement for proper cardiac fusion: 
expression and function of the small heat shock protein, Hsp27. 
 Hsp27 is one of the most widely distributed and most studied of the small heat shock 
proteins (reviewed in Ferns et al., 2006). The small heat shock proteins (sHSP) are a 
ubiquitous family of molecular chaperones, consisting of ten members in humans (Kappe et 
al., 2003). Proteins in the sHSP family have molecular weights ranging from 16 to 25 kDa 
and generally consist of a conserved carboxy-terminal α-crystallin domain, a variable amino 
terminus and a short variable carboxy tail. Functionally, sHSPs have been demonstrated to be 
cytoprotective in response to cellular stress, and have been implicated in many cellular 
processes, including cytoskeletal dynamics and apoptosis. Furthermore, sHSP function has 
been implicated in a variety of human disease states, such as cataract, cancer, ischemic 
injury, myopathy, and neuropathy (reviewed in (Sun and MacRae, 2005). Changes in Hsp27 
expression have been observed in cells and tissues exposed to many stress conditions, 
including oxidative damage (Arrigo, 2001; Baek et al., 2000; Dalle-Donne et al., 2001; 
Escobedo et al., 2004; Huot et al., 1996; Komatsuda et al., 1999; Mehlen et al., 1995), metal 
 18
toxicity (Bonham et al., 2003; Leal et al., 2002; Somji et al., 1999), and ischemia (Hollander 
et al., 2004; Reynolds and Allen, 2003; Shelden et al., 2002; Vander Heide, 2002), as well as 
in disease states such as cardiac hypertrophy (Knowlton et al., 1998; Scheler et al., 1999), 
and muscle myopathies (Benndorf and Welsh, 2004). In addition, a role for HSP27 function 
has been implicated in many cellular processes, including protein chaperone activity (Jakob 
et al., 1993), regulation of cellular glutathione levels  (Arrigo, 2001; Baek et al., 2000), 
apoptotic signaling (Bruey et al., 2000; Paul et al., 2002), inhibition of actin polymerization 
(Benndorf et al., 1994; Miron et al., 1991; Rahman et al., 1995), and stabilization of actin 
filament arrays (Huot et al., 1996; Lavoie et al., 1993a; Lavoie et al., 1993b; Lavoie et al., 
1995). Hsp27 has been shown to be expressed during both skeletal and cardiac muscle 
development in several organisms, including human (Shama et al., 1999), mouse (Gernold et 
al., 1993), pig (David et al., 2000) and zebrafish (Mao et al., 2005; Mao and Shelden, 2006).  
However, the biological significance of this developmentally regulated expression has not 
been analyzed in developing embryos. Furthermore, previous attempts to identify Xenopus 
laevis (X. laevis) orthologues of the Hsp27 family have reportedly failed (Norris et al., 1997). 
In the present studies I report the sequence and expression of the X. laevis orthologue of heat 
shock protein 27 (XHsp27).  I demonstrate using anti-sense morpholinos that XHSP27 is 
required for proper fusion of cardiac precursors and for actin organization in developing 
cardiac and skeletal muscle. I further demonstrate that cardiac specification and 
differentiation appear unaltered as assayed by several markers of cardiac precursor and 
differentiated cardiomyocyte populations.  
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Figure 1.1. Diagram Depicting Cardiac Precursor Induction and Migration  
(A) Blastula stage 10 embryo shown in cross section. Image on the left shows orientation and 
tissue domains of image on the right. Wnt and BMP inhibitors from Spemann organizer 
antagonize Wnt and BMP signals from ventral region. Cardiac precursors are specified in 
regions of Wnt signal inhibition and BMP signaling. (B) Neurulation stage 14 embryo shown 
laterally.  Heart field precursors migrate anteriorly during this stage. (C) Early tailbud stage 
26. Heart precursors migrate ventrally to fuse at the ventral midline. 
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Figure 1.1. Diagram Depicting Cardiac Precursor Induction and Migration 
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Figure 1.2. Diagram Depicting Cardiac Precursor Fusion  
Diagram of transversely cross sectioned embryos at indicated stages. Heart precursors fuse at 
the midline, endocardium migrates dorsally and medially, and the endocardium is enveloped 
by differentiating myocardium. 
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Figure 1.2. Diagram Depicting Cardiac Precursor Fusion 
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Figure 1.3. Diagram Depicting Cardiac Looping Morphogenesis  
Lateral views of heart tubes from stage 29 through stage 38 embryos depicting rearrangement 
of the chamber regions in the developing heart. Blue arrows indicate inflow and red arrows 
indicate outflow. 
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Figure 1.3. Diagram Depicting Cardiac Looping Morphogenesis 
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CHAPTER II 
DEVELOPMENTAL EXPRESSION OF THE XENOPUS LAEVIS TBX20 
ORTHOLOGUE1
A.   Introduction 
 The T-box family of transcription factors is a large family of proteins required for 
both early cell fate decisions, such as those necessary for formation of the basic vertebrate 
body plan, as well as for differentiation and organogenesis. The role of the T-box genes in 
these processes is emphasized by the observation that T-box genes when mutated give 
dramatic phenotypes in mouse and zebrafish. Furthermore, T-box genes are implicated in a 
number of human congenital malformations and are amplified in a subset of cancers 
(reviewed in Papaioannou, 2001; Smith, 1999; Wilson and Conlon, 2002). The T-box family 
has recently been shown to comprise approximately 0.1 % of genomes as diverse as C. 
elegans and human and have been identified in a wide variety of chordates from ctenophore 
to human while being completely absent in genomes from other phyla (e.g. Arabidopsis 
thaliana). For many of these genes clear homologues exist such as Brachyury, which 
displays a high degree of sequence similarity, expression pattern, and function between a 
variety of vertebrates including fish, frog, dog and mouse. However, other T-box genes 
appear to be unique to a particular species. For instance, VegT, a T-box gene thought to be 
                                                 
1 This work was originally published in Brown, D. D., Binder, O., Pagratis, M., Parr, B. A. and Conlon, F. L. 
(2003). Developmental expression of the Xenopus laevis Tbx20 orthologue. Dev Genes Evol 212, 604-7.. 
  
required for endoderm formation in Xenopus, has no apparent homologue or orthologue in 
mouse or human (reviewed in Wilson and Conlon, 2002).  
 Two sets of clinical studies have provided direct evidence for a role for T-box genes 
in heart development and differentiation with Tbx1 deleted in patients with the DiGeorge 
syndrome (Jerome and Papaioannou, 2001; Lindsey et al., 2001; Merscher et al., 2001), and 
Tbx5 often mutated in patients with the congenital heart disease, Holt-Oram Syndrome 
(Basson et al., 1999; Li et al., 1997). In addition to Tbx1 and Tbx5, recent studies in human, 
mouse, chick and zebrafish have implicated a third member of the T-box gene family, 
Tbx12/20, in heart development (Ahn et al., 2000; Carson et al., 2000; Griffin et al., 2000; Iio 
et al., 2001; Kraus et al., 2001; Meins et al., 2000). To further address the role of Tbx20 in 
early heart development, I have identified and analyzed the expression of a Tbx20 orthologue 
in Xenopus laevis (X. laevis). 
 
B.   Materials and Methods 
Isolation of Tbx20 cDNA 
 Degenerate primers were designed based on Drosophila H15 and C. elegans Tbx12 
sequences (Agulnik et al., 1997; Brook and Cohen, 1996a). RT-PCR was performed using 
these primers on stage 36 X. laevis RNA. Additional X. laevis sequence was obtained by a 
second round of amplification using primers derived from mouse, human, and zebrafish 
Tbx20 sequences (Ahn et al., 2000; Carson et al., 2000; Griffin et al., 2000; Meins et al., 
2000). This 928bp clone was used to screen a cDNA mixed stage (19-26) X. laevis cDNA 
library (generous gift of Aaron Zorn) by PCR. Partial sequencing and restriction mapping 
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were used to construct a full-length copy of the gene by cloning overlapping fragments into 
pBluescript II KS (Stratagene). 
 
Ribonuclease Protection Assay  
 To make the RNase probe, the 3-prime end of Tbx20 was subcloned into pGEM-4Z 
(Promega). This probe does not contain sequences within the putative T-box domain and is 
assumed to be Tbx20-specific. Ornithine decarboxylase (ODC) was used as an internal 
loading control and tRNA was used as a negative control (Isaacs et al., 1992). Briefly, the 
constructs were linearized and probe was synthesized using 32P-UTP (PerkinElmer). Total 
RNA was isolated from staged embryos from early gastrula (stage 10) to early tadpole (stage 
36) using TRIZOL reagent according to manufacturer (Invitrogen). Probe was hybridized to 
labeled RNA in 1X PIPES Buffer (Sigma) and 50% formamide (Sigma). Unprotected probe 
was degraded for 30 minutes at 37°C using 200 U RNase T1 (Ambion) in 0.1M Tris, pH 7.4 
(Sigma), 0.05M EDTA (Sigma) and 0.3M NaCl (Sigma). Phenol/chloroform extracted probe 
was then run on 6% polyacrylamide gel and the dried gel was exposed to X-OMAT-AR film 
(Kodak).  
 
Reverse Transcription Polymerase Chain Reaction 
 RNA was isolated from ten embryos per stage per condition using the RNeasy kit 
(Qiagen) according to the manufacturer’s instructions. The resulting RNA was quantified 
using a UV spectrophotometer (Shimadzu UV-1601), and 100 ng of RNA for each reaction 
was used to synthesize cDNA with Superscript II reverse transcriptase (Invitrogen). Total 
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reaction volume for cDNA synthesis was 20 µl. Resulting cDNA (2 µl) was then used as 
template in PCR reactions with Taq polymerase.  
 
Whole-mount RNA in situ hybridization 
 Whole-mount in situ hybridizations were performed as previously described (Harland 
1991). XTbx20 digoxigenin-labeled probes were synthesized using T7 RNA polymerase from 
pXTbx20∆5’3’ (the initially identified partial Tbx20 cDNA clone) linearized with XhoI. 
Embryos were cleared using 2:1 benzyl benzoate/benzyl alcohol. 
 
C.   Results 
XTbx20 Shares High Sequence Homology to Tbx20 Orthologues 
 To isolate X. laevis Tbx20, we designed a set of degenerate primers based on the 
published Drosophila H15 and C. elegans Tbx12 sequences (Agulnik et al., 1997; Brook and 
Cohen, 1996a). These primers were used to isolate a clone from Stage 36 X. laevis RNA. 
Additional X. laevis sequence was obtained by a second round of amplification using primers 
derived from mouse, human, and zebrafish Tbx20 sequences (Ahn et al., 2000; Carson et al., 
2000; Griffin et al., 2000; Meins et al., 2000). This 928bp clone was in turn used to screen a 
cDNA mixed stage (19-26) X. laevis cDNA library (generous gift of Aaron Zorn) by PCR. 
Partial sequencing and restriction mapping were used to construct a full-length copy of the 
gene by cloning overlapping fragments into pBluescript II KS (Stratagene). The clone was 
sequenced from both ends with a minimum of 4-fold coverage and shown to contain a 
1741bp insert with an open reading frame of 441 amino acids (GenBank Accession number: 
AY154394; Fig. 2.1A). Sequence analysis revealed the clone to have 84% identity with 
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human Tbx20 (Meins et al., 2000), 90% with mouse Tbx12/20 (Carson et al., 2000; Kraus et 
al., 2001), and 91% to chicken Tbx20 (Fig. 2.1B; Iio et al., 2001; Showell et al., 2004). Based 
on sequence (Fig. 2.1), expression analysis (Fig 2.2, 2.3), and current T-box nomenclature, 
we refer to this gene as the X. laevis orthologue of Tbx20. 
 
XTbx20 Expression is Developmentally Regulated in Heart, Brain, Eye, and Cement 
Gland 
 I determined the onset and relative levels of Tbx20 during X. laevis development by 
RNase protection analysis using a probe derived from the 3-prime end of Tbx20 on staged 
embryos from early gastrula (stage 10) to early tadpole (stage 36; Fig. 2.2). This probe does 
not contain sequences within the putative T-box domain and therefore is assumed to be 
Tbx20 specific. Ornithine decarboxylase (ODC) was used as an internal loading control and 
tRNA was used as a negative control. Tbx20 transcripts are first detected at low but 
consistent levels by early neural stage (stage 16) with expression then increasing by stage 19 
and remaining relatively constant until a sharp drop off at later neurula stages (stages 23 to 
28). However, there is a sharp increase in expression between early (stage 30) and mid-
tadpole stages (stage 36; Fig. 2.2). RT-PCR analysis shows no maternal expression as judged 
in unfertilized eggs and early gastrula embryos (stage 10). 
 To determine the spatial pattern of expression I performed whole mount in situ 
hybridizations on staged X. laevis from early gastrula (stage 10) to mid-tadpole (stage 40). 
Consistent with RNase protection and RT-PCR analysis, we first detect Tbx20 expression by 
in situ hybridization at late gastrula stages in the region of the most anterior developing 
cement gland (stage 13; Fig. 2.3A) and at slightly later stages, in the heart field (stage 16; 
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Fig. 2.3B). Tbx20 is expressed in the heart field before fusion of the primordium along the 
ventral midline. Thus, together with Tbx5 (Horb and Thomsen, 1999) and the Nkx paralogues 
(Newman, 1998), Tbx20 is one of the earliest markers of X. laevis cardiac tissue. Expression 
of Tbx20 in the heart gradually increases during development (compare Fig. 2.3B with Fig. 
3D) and by mid-tadpole (stage 35), expression is found throughout the cardiac region (Fig. 
2.3E, F, I, K) including the atrial and ventricular tissue, the inflow and outflow tract, and the 
septum transversum (Fig. 2.3F), while being completely absent from more posterior tissues 
such as the liver (Fig. 2.3C-E, I). In addition, Tbx20 is expressed in both tissue layers of the 
heart, with relatively high levels in the myocardial layer and lower levels in the endocardial 
layer (Fig. 2.3K). Therefore, Tbx20 is expressed at the same time and in many regions of the 
heart that also express the heart markers Tbx5 and Nkx2.5 (Horb and Thomsen, 1999; 
Tonissen et al., 1994).  
 In the cement gland, the most anterior neural ectodermal tissue, Tbx20 is gradually 
restricted to the ventral half of the gland by stage 27 (Fig. 2.3C), and expression decreases 
during neurula and early tadpole stages (Fig. 2.3E, I) such that by stage 40, Tbx20 can no 
longer be detected in the tissue. In addition to the cement gland and heart, high levels of 
Tbx20 expression are found in the external jugular vein, the lung bud (Fig. 2.3F), and the 
cloacal aperture (Fig. 2.3H) and very low levels in the retina and transient low levels in the 
notochord (Fig. 2.3E). Similar to reports in mouse, chick, and zebrafish (Ahn et al., 2000; 
Carson et al., 2000; Iio et al., 2001; Kraus et al., 2001), we also observe expression in 
rhombomeres 2, 4, 6, and 8 (Fig. 2.3E-G, I), and as shown by transverse and parasagittal 
sections through stage 35 embryos, in a subset of motor neurons emerging from these 
rhombomeres (Fig. 2.3I, J, L). However, in contrast to the mouse, we never detect Tbx20 
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expression in the liver (Fig. 2.3C-E, I; (Kraus et al., 2001). Therefore, although Tbx20 
displays a very high degree of sequence conservation across species, only a subset of tissues, 
such as the rhombomeres, show a conservation of expression, while other sites of expression 
appear to be unique to X. laevis, such as the lung bud and jugular vein. 
 
D.   Discussion 
 In this study I have successfully isolated the X. laevis orthologue of Tbx20. Protein 
sequence analysis reveals that XTbx20 shares high homologies with other known orthologues 
of Tbx20, ranging from 84% to 91% identity . Furthermore, I have demonstrated that 
expression of XTbx20 during embryogenesis appears to be highly conserved between X. 
laevis and other vertebrates. Expression analysis reveals that XTbx20 is expressed throughout 
the developing heart and throughout the entire course of cardiogenesis. In addition XTbx20 
mRNA can be detected in domains within specific rhombomeres in the hindbrain, in the eye, 
in the cement gland, and in the peri-anal region. Considering the very high sequence 
homology as well as conservation in expression between XTbx20 and its homologues, these 
data suggest that the function of XTbx20 is likely conserved as well. Furthermore, the high 
degree of conservation suggests that whatever roles XTbx20 plays in embryogenesis are 
possibly integral to proper morphogenesis. XTbx20 expression within cardiac precursors 
begins during early stages of precursor migration, prior to fusion at the midline. These data 
suggest that XTbx20 may be involved in specification or differentiation of these precursors. 
These observations further implicate Tbx20 as a potential candidate in leading to human 
congenital disorders when mutated.  
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Figure 2.1. X. laevis Tbx20 is highly homologous to other Tbx20 family members  
(A, B) Comparative sequence analysis of Tbx20. Analysis was performed with the GeneDoc 
program. (A) Alignment of vertebrate Tbx20 proteins. Fully conserved amino acids including 
those containing conservative substitutions are shaded in dark gray. Lighter shading 
represents lower conservation. The conserved T-box domain is underlined in black. (B) 
Vertebrate Tbx20 amino acid conservation. The percentage of identical amino acid residues 
(identity) and the percentage of conservative substitutions and identical residues (similarity) 
are given for comparison between Tbx20 proteins. 
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Figure 2.1. X. laevis Tbx20 is highly homologous to other Tbx20 family members 
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Figure 2.2. Expression of Tbx20 is temporally regulated during embryogenesis. 
Temporal expression of X. laevis Tbx20 as detected by RNase Protection Assay. ODC is 
included in the lower panel as an internal loading control.  
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Figure 2.2. Expression of Tbx20 is temporally regulated during embryogenesis. 
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Figure 2.3. Tbx20 is expressed in the developing heart, eye, cement gland, and 
hindbrain 
(A-L) Expression of Tbx20 during Xenopus laevis development as detected by whole mount 
in situ hybridization. (A) Anterior view of a stage 13 embryo. Dorsal side is facing up. (B) 
Anterior view of a stage 16 embryo. Dorsal side is facing up.  (C) Ventral view of the 
anterior portion of a stage 27 embryo. (D) Ventral view of the anterior portion of a stage 32 
embryo.  (E)  Lateral view of the anterior portion of a stage 35 embryo. (F) Higher 
magnification of (E). (G) Dorsolateral view of a stage 35 embryo. (H) Ventral view of the 
posterior portion of a stage 27 embryo. (I-L) Sections of stage 35 embryos. (I) Anterior view 
of a parasagittal section.  (J)  Transverse section through the anterior region. (K, L) Higher 
magnifications of (J). ca cloacal aperture, cg cement gland, e endocardium, ey eye, h heart, 
hb hindbrain, hp heart primordium, it inflow tract, jv jugular vein, l liver, lb lung bud, m 
myocardium, mn motor neuron, nch notochord, ot outflow tract, st septum transversum, R2-
R8 rhombomeres 2, 4, 6, and 8.  
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Figure 2.3. Tbx20 is expressed in the developing heart, eye, cement gland, and 
hindbrain 
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CHAPTER III 
TBX5 AND TBX20 ACT SYNERGISTICALLY TO CONTROL VERTEBRATE 
HEART MORPHOGENESIS2
 
A.   Introduction 
 The vertebrate heart constitutes the earliest functional organ in the developing 
embryo and about 1% of all live births exhibit congenital heart disease (Hoffman, 1995a; 
Hoffman, 1995b; Payne et al., 1995). It is becoming increasingly clear that a complex 
molecular regulatory network is required to initiate and complete the formation of a 
functional heart.  The proteins implicated in this process include a number of transcription 
factors from a range of transcription factor families, including the T-box, basic helix-loop-
helix homeodomain, zinc finger, and MADS domain families (Cripps and Olson, 2002; 
Harvey, 2002; Zaffran and Frasch, 2002).  
The T-box family of transcription factors is a large family of proteins involved in 
determining early cell fate decisions and controlling differentiation and organogenesis. Two 
sets of clinical data have provided direct evidence for the involvement of T-box genes in 
human heart development (Packham and Brook, 2003; Ryan and Chin, 2003).  Deletions of 
Tbx1 have been found in patients with DiGeorge syndrome (Baldini, 2004; Chieffo et al., 
1997; Jerome and Papaioannou, 2001; Lindsey et al., 2001; Merscher et al., 2001; Yagi et al., 
                                                 
2 This work was originally published in Brown, D. D., Martz, S. N., Binder, O., Goetz, S. C., Price, B. M. J., 
Smith, J. C. and Conlon, F. L. (2005). Tbx5 and Tbx20 act synergistically to control vertebrate heart 
morphogenesis. Development 132, 553-563. 
  
2003), and mutations in Tbx5 are associated with Holt-Oram Syndrome (HOS), a congenital 
heart disease characterized by defects in heart formation and upper limb development 
(Basson et al., 1997; Li et al., 1997). Clinical studies of HOS patients have demonstrated a 
fundamental role for Tbx5 in heart development. HOS is a highly penetrant autosomal 
dominant condition associated with skeletal and cardiac malformations (Newbury-Ecob et 
al., 1996). Patients with HOS often carry mutations within the coding region of the T-box 
transcription factor Tbx5 (Basson et al., 1997; Basson et al., 1999; Benson et al., 1996; Li et 
al., 1997). The role of Tbx5 in heart development, and in the HOS disease state, is further 
supported by recent gene-targeting experiments in mouse. These studies demonstrate that mice 
heterozygous for mutations in Tbx5 display many of the phenotypic abnormalities of HOS 
patients (Bruneau et al., 2001) and show that TBX5 is required for growth and differentiation 
of the left ventricle and atria as well as for proper development of the cardiac conduction 
system (Moskowitz et al., 2004). Similar defects are seen in the zebrafish Tbx5 mutant 
heartstrings, suggesting that the expression and function of TBX5 is conserved throughout 
vertebrate evolution (Garrity et al., 2002). 
Previously, I described the cloning and expression of the Xenopus laevis (X. laevis) 
Tbx20 orthologue, Tbx20 (Chapter II; Brown et al., 2003). Studies of Tbx20 have 
demonstrated that along with Tbx5, Tbx20 is one of the first genes expressed in the vertebrate 
cardiac lineage. Moreover, Tbx20 is expressed at the same time and in many of the same 
regions of the heart that also express the heart markers Tbx5, Nkx2-5, and Gata4 (Horb and 
Thomsen, 1999; Laverriere et al., 1994; Serbedzija et al., 1998; Tonissen et al., 1994). 
 Despite our knowledge of the expression pattern of Tbx20, little is known of Tbx20 
function in heart development. In the zebrafish, it has recently been observed that eliminating 
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endogenous TBX20 (HrT) via morpholinos leads to cardiac defects (Szeto et al., 2002).  
Specifically, TBX20 knockdown in zebrafish leads to dysmorphic hearts and a loss of blood 
circulation.  The morphological defects are not apparent until the cardiac looping stage, 
despite high levels of Tbx20 during the earlier stages of specification and development 
suggesting that other T-box genes may act redundantly with Tbx20 during early heart 
development.   
In this study I investigate the cellular and molecular relationship between Tbx5 and 
Tbx20 in X. laevis. I show that the phenotypes of knocking down TBX5 and TBX20 are 
highly similar, with embryos derived from either Tbx5 or Tbx20 morpholino injections 
displaying profound morphological defects including pericardial edema, reduced cardiac 
mass, and loss of circulation. In addition, I show that the morphological phenotype is not a 
reflection of alterations in the specification, commitment, or differentiation of cardiac tissue. 
Thus, in addition to sharing a number of molecular properties, I show that Tbx5 and Tbx20 
function in a non-redundant fashion and are essential for cardiac morphogenesis. However, 
despite the similarities in phenotype and shared molecular properties, Tbx5 and Tbx20 also 
have independent roles in heart development.  
Given the similarity in TBX5 and TBX20 morphant phenotypes, I investigated the 
pathways by which Tbx5 and Tbx20 function. I show that TBX5 and TBX20 do not function 
in a linear pathway (i.e. Tbx20 does not act downstream of Tbx5, and vice versa), but rather 
imply a synergistic role for these two proteins during early heart development. Consistent 
with this proposal, I show that TBX5 and TBX20 can physically interact, map the interaction 
domains, and show an interaction for the two proteins in cardiac development, therefore 
providing the first evidence for interaction between members of the T-box gene family. 
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B.   Materials and Methods 
DNA Constructs 
To construct pXTbx20-V5-His the coding region of XTbx20 minus the stop site was 
PCR-amplified from pXTbx20-Full-length using sequence-specific primers (XTbx20-
Forward - 5’ CCCAAGCTTGGGATGGAATACACTCCTTCT 3’, XTbx20-reverse - 5’ 
CCGCTCGAGCGGTACAAATGGTGTCATCAC 3’).  The forward primer contained a 
flanking HindIII site and the reverse primer contained a flanking XhoI site for other cloning 
purposes.  The resulting PCR product was then TA-cloned into pcDNA3.1/V5-His TOPO TA 
(Invitrogen) in-frame with the V5 epitope. pXTbx20∆5’3’ is the original partial XTbx20 
clone containing a 928 bp XTbx20 fragment (nt 627-1554 of full-length cDNA) 
encompassing most of the T-Box and the 3’ end and lacking most of the 5’ and part of the 3’ 
end (Brown et al., 2003). The pXTbx20-Full-length construct is our original full length 
XTbx20 cDNA construct (Brown et al., 2003). XANF was generously provided by Paul Krieg 
(Small and Krieg, 2000). The cardiac troponin I pXTnIc plasmid was generously provided 
by Tim Mohun (Logan and Mohun, 1993). pXTbx5 contains the full-length coding region of 
XTbx5 cloned into pBLUESCRIPT II KS+ with HindIII and NotI (Frank Conlon). Sequence 
analysis revealed that the clone shows extensive homology to a partial sequence of the 
second X. laevis allele of Nkx2-5 (accession AF283102). The clone is predicted to be full-
length and in vitro translation of the protein gave a band of the correct size. The clone is 
referred to as pCRNkx-2.5B (accession number AY644403).  To construct the pBS-Nkx2-5 
hybridization probe, Nkx2-5 was subcloned into pBLUESCRIPT II KS+.  
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Transient Transfections 
 293T cells were plated at 1 X 106 cells/well in six-well tissue culture plates 24 hours 
prior to transfection.  Plasmids used in transients are: the Nppa promoter-luciferase reporter 
(Bruneau et al., 2001), pTbx5-V5, pTbx20-V5, pCMV-LacZ; pBS/KS.  The amount of 
luciferase reporter plasmid DNA was kept constant at 100 ng for Tbx5, while titering in 
Tbx20 (25 ng-100 ng). Expression vector plasmid DNA was kept constant at 100 ng total and 
50 ng of LacZ reporter plasmid was used.  Total amount of DNA was kept constant at 2 µg 
and transfected using Lipofectamine 2000 (Invitrogen).  Plasmid DNA was diluted in OPTI-
MEM (GibcoBRL) and complexes were allowed to form for 25 minutes at RT and added to 
each well.  48 hours post-transfection, cells were harvested using M-PER (Pierce) with gentle 
shaking.  Luciferase activity was normalized to ß-galactosidase activity.  All assays were 
done three independent times in triplicate.  Results were graphed using normalized Relative 
Luciferase Units (RLUs). 
 
Nuclear Localization 
 NIH/3T3 cells were seeded in chamber slides at 6 x 103 cells/chamber 24 hours prior 
to transfection.  Cells were transfected with 187.5 ng pTbx20-V5 or pTbx5-V5 per chamber 
using 1.25 µl Polyfect (QIAgen) transfection reagent according to manufacturer’s protocol.  
At 48 hours, cells were washed twice with PBS and fixed in MEMFA for 1 hour (2 ml 10X 
MEM, 2 ml Formaldehyde, 16 ml H2O) at 4°C.  Cells were washed twice with PBST (PBS + 
0.1% Triton), blocked in PBST + 10% Fetal Bovine Serum for 1 hour at 4°C, incubated at 
4°C overnight with anti-V5 (Invitrogen) diluted 1:1000 in PBST+Serum.  Cells were washed 
three times, blocked for 1 hour, then incubated for 1 hour at RT with goat anti-mouse Cy2 
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(Jackson ImmunoResearch) diluted 1:200 in PBST+Serum.  This process was repeated using 
anti-phosphotyrosine (Upstate Biotechnology) as 1° antibody to visualize the cytoplasmic 
compartment and goat anti-mouse Cy3 (Jackson ImmunoResearch) 2° antibody.  Cells were 
washed three times, cover-slipped and analyzed by confocal microscopy on a Zeiss LSM 
410. 
 
Embryo Injections  
 Preparation and injection of X. laevis embryos was carried out as previously 
described (Wilson and Hemmati-Brivanlou, 1995). Embryos were staged according to 
Nieuwkoop and Faber (Nieuwkoop and Faber, 1967). Two antisense morpholino 
oligonucleotides each were designed against the Tbx5 and Tbx20 5’ UTRs and start sites. 
Morpholinos were obtained from Gene Tools, LLC. with the following sequences: Tbx20-
MO1, 5' AAT CCA CTT CCA AGG GCA GTT GCT T 3'; Tbx20-MO2, 5' GTT TGG GAG 
AAG GAG TGT ATT CCA T 3'; Tbx5-MO1, 5' TTA GGA AAG TGT CTC TGG TGT TGC 
C 3'; Tbx5-MO2, 5' CAT AAG CCT CCT CTG TGT CCG CCA T 3'; Control MO, 5' CCT 
CTT ACC TCA GTT ACA ATT TAT A 3'. The human ß-globin splice-mutant standard 
control morpholino from Gene Tools was used as control. Equal amounts of both Tbx5 
morpholinos were used in all injections. This combination is referred to in the text and 
figures as “TBX5MO”. Tbx20 morpholinos were also injected in combination, and referred 
to as “TBX20MO”. TBX5MO was injected at the optimal (40 ng) or suboptimal (20 ng) 
doses, and TBX20MO was injected at the optimal (80 ng) or suboptimal (40 ng) doses.  
“Optimal dose” is defined as the dose empirically found to be efficient at blocking protein 
translation both in vitro and in vivo, and inducing a cardiac phenotype in nearly 100% of 
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injected embryos, while “suboptimal dose” refers to the dose empirically found to be below 
the threshold of the full cardiac phenotype-inducing dose.  
 
Whole-mount RNA in situ hybridization 
 Whole-mount in situ hybridizations were performed as previously described (Harland 
1991). XANF digoxigenin-labeled probes were synthesized using T7 RNA polymerase from 
pXANF linearized with BamHI (Small and Krieg, 2000). XTbx5 digoxigenin-labeled probes 
were synthesized using T7 RNA polymerase from pXTbx5 linearized with HindIII.    
XNkx2.5 digoxigenin-labeled probes were synthesized using T7 RNA polymerase from 
pXNkx2.5 linearized with XhoI (Tonissen et al., 1994). XTbx20 digoxigenin-labeled probes 
were synthesized using T7 RNA polymerase from pXTbx20∆5’3’ linearized with XhoI. To 
make the cardiac troponin I probe pXTnIc was cut with Not1 and anti-sense digoxigenin-
labeled probe was synthesized using T7 RNA polymerase. Embryos were cleared using 2:1 
benzyl benzoate/benzyl alcohol. 
 
Immunohistochemistry 
Embryos were collected and fixed for 2 hours at 4 ºC in 4% paraformaldehyde and 
rinsed in PBS, incubated overnight in 30% sucrose in PBS at 4 ºC, mounted in OCT 
cryosectioning medium (Tissue Tek) and snap frozen. Cryostat sections (14 µm) sections 
were rinsed with wash buffer (PBS, 1% Triton, 1% serum), incubated at 4°C overnight with 
anti-tropomyosin (1:50; Developmental Studies Hybridoma Bank) (Kolker et al., 2000), and 
phalloidin conjugated to Alexa 488 flourophore (Molecular Probes). Sections were then 
rinsed with wash buffer and incubated with anti-mouse Cy3-conjugated secondary antibody 
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(1:200), (Sigma). Sections were rinsed and incubated for 20 minutes at RT with DAPI, cover 
slipped and visualized on a Zeiss LSM410 confocal microscope. 
 
Translation Inhibition by Morpholinos 
 In vitro translations were performed using TNT® Coupled Reticulocyte Lysate 
System (Promega) following the manufacturer’s protocol. We have recently demonstrated 
that X. laevis SHP-2 is uniformly expressed throughout early development (Y. Langdon and 
FLC, unpublished data) and anti-PTP1D/SHP2 1° antibody was used at 1:2500 (Transduction 
Laboratories) as a loading control with peroxidase-conjugated AffiniPure donkey anti-mouse 
(H+L) 2° antibody (1:10,000).  V5-tagged proteins were probed with anti-V5 1° antibody 
(Invitrogen) at 1:5000 dilution, and peroxidase-conjugated AffiniPure Donkey anti-mouse 
(H+L) 2° antibody (Jackson ImmunoResearch Laboratories) at 1:10,000 dilution. For in vivo 
translation analyses, embryos were injected with MOs and mRNA at the one-cell stage and 
animal caps cut at stage 8.  At sibling stage 10, and 10 animal caps per treatment were 
collected and lysed in 100 µl of lysis buffer: 200 mM NaCl, 20 mM NaF, 50 mM Tris pH 
7.5, 5 mM EDTA, 1% IGEPAL, 1% Triton X-100 (Sigma), Complete EDTA-free Protease 
Inhibitor (Roche).  Lysates were resolved on 12% SDS-PAGE gels, and visualization was 
carried out using Western Lightning Chemiluminescence Reagent Plus (PerkinElmer Life 
Sciences, Inc.). 
 
Benzidine Staining 
 Erythrocytes were detected using a modified version of the benzidine histochemical 
staining method (Hemmati Brivanlou and Thomsen, 1995; Orkin et al., 1975).  Briefly, 
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embryos were fixed at stage 43 in 12% glacial acetic acid and 4% benzidine (Sigma) for 5 
minutes and stained with the addition of 0.3% hydrogen peroxide.  The staining reaction was 
allowed to proceed for 10 minutes at RT.  The embryos were washed with 12% glacial acetic 
acid three times, fixed for 1.5 hours in MEMFA, and cleared using 2:1 benzyl 
benzoate/benzyl alcohol. 
 
Glutathione-S-Transferase Pulldown Assays 
 GST pulldown assays were performed using the MicroSpin GST Purification Module 
(Amersham Biosciences) according to the manufacturer’s protocol. GST constructs were 
transformed into BL21-Gold (DE3) cells (Stratagene) for protein induction. Transformed 
cells were grown at 37°C to O.D.A600=0.8 and GST proteins were induced for 1.5 hours at 20-
27°C with 1mM IPTG (Amersham Biosciences). Hemagglutinin (HA)-tagged putative 
interacting proteins were produced in 293T cells. Lysates were sonicated 3 times for 10 
seconds prior to centrifugation at 12,000 rpm at 4°C for 10 minutes, and the supernatant was 
collected. GST-fusion protein lysates and putative interacting protein lysates were loaded on 
GST columns, incubated for 1.5 hours at 25°C, eluted, electrophoresed on a 12% SDS-PAGE 
gel, and transferred to PolyScreen PVDF Transfer Membranes. HA-tagged proteins were 
detected with mouse HA.11 primary antibody (1:1,000, Covance Research Products) and 
with peroxidase-conjugated AffiniPure donkey anti-mouse (H+L) secondary antibody 
(1:10,000). GST-fusion proteins were detected with rabbit anti-GST primary antibody 
(1:25,000, Sigma-Aldrich) and with Peroxidase-conjugated AffiniPure donkey anti-rabbit 
(H+L) secondary antibody (1:10,000, Jackson ImmunoResearch Laboratories).  
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C.  Results 
TBX5 and TBX20 are Required for Heart Morphogenesis 
To analyze the requirement for Tbx5 and Tbx20 in cardiogenesis, antisense 
morpholinos were designed against the 5’ UTRs and translational start sites of the respective 
cDNAs (Fig. 3.1A; Heasman et al., 2000). Due to the lack of antibodies against endogenous 
TBX5 or TBX20, I tested the efficiency and specificity of morpholino translation inhibition 
using V5 epitope-tagged versions of TBX5 and TBX20 both in vitro and in vivo. To this end, 
transcription/translation reactions were incubated with each cDNA construct alone and 
together with increasing concentrations of morpholinos (Fig. 3.1B, C). TBX20MO was 
included as control for TBX5MO and vice versa, and a ControlMO used for both. Results 
from these assays show that TBX5MO blocks translation of TBX5-V5 while TBX20MO and 
ControlMO do not. Similarly, TBX20MO blocks translation of TBX20-V5 in vitro (Fig. 
3.1B, C).   
To determine if TBX5MO and TBX20MO block translation in vivo, I injected Tbx5-
V5 or Tbx20-V5 mRNA alone or in the presence of morpholinos into one-cell stage embryos. 
Animal caps were cut at stage 8 and allowed to develop to stage 10, at which point Western 
blot analyses were performed. Results from these studies demonstrate that in animal caps, 
TBX5MO blocks TBX5-V5 translation, while TBX20MO blocks TBX20-V5 translation 
(Fig. 3.1D, E). I have further shown via sequence alignments that Tbx5 does not contain 
binding sites for the Tbx20 morpholinos and vice versa (Fig. 3.2). I did note that the 
introduction of TBX20MO results in a slight decrease in TBX5 in vivo, and vice versa (see 
Discussion). 
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 To address the question of whether Tbx20 morpholinos can theoretically bind the 
Tbx5 transcript or whether Tbx5 MOs can bind the Tbx20 transcript, I performed sequence 
alignments using the GeneDoc program. I could find no significant homology between either 
Tbx5 MO and the Tbx20 transcript or Tbx20 MOs on the Tbx5 transcript (Fig. 3.2). The 
alignments shown represent the best matches identified by the GeneDoc software, yet even 
these matches have a high degree of mismatch as well as gaps. Studies have shown that 
introducing as few as four mismatches into a morpholino can result in complete abrogation of 
the morpholino effects (Araki and Brand, 2001). Thus, the in vitro translation results, 
sequence alignments, and published data on morpholino efficacy suggest that our 
morpholinos do not cross react. 
To determine the requirement of TBX5 and TBX20 in heart development, I injected 
TBX5MO, TBX20MO, or ControlMO into one-cell stage embryos. No significant 
differences are seen between TBX5 morphants, TBX20 morphants, control morphants, or 
uninjected siblings throughout gastrulation and neurulation stages. However, a slight delay in 
developmental stage is evident in TBX5 and TBX20 morphants relative to control morphants 
and uninjected embryos by neurulation stage, (~st. 16).  By cardiac looping stages, (~st. 38) 
(Kolker et al., 2000; Mohun and Leong, 1999; Mohun, 2000; Newman and Krieg, 1999) a 
reduction in cardiac mass is evident in the morphants, and by stage 38 both morphants 
display grossly abnormal heart morphology (Fig. 3.3A- F). At this stage, 82% of TBX5 
morphants and 100% of TBX20 morphants display prominent cardiac defects, as scored by 
the presence of an unlooped heart tube, a reduction in cardiac mass and the presence of a 
pericardial edema (Fig. 3.3G). After terminal cardiomyocyte differentiation has begun (~st. 
45; Kolker et al., 2000; Mohun and Leong, 1999; Mohun, 2000; Newman and Krieg, 1999) 
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TBX5 and TBX20 morphants display dramatically smaller hearts and in many embryos 
cardiac tissue is barely detectable (Fig. 3.3E, F). However, the remaining cardiac tissue still 
retains some degree of contractility, but confined to a small patch of contractile tissue in the 
dorsal-most aspect of the cardiac cavity. Both TBX5 and TBX20 morphants also display 
abnormal eyes, which is consistent with studies showing the involvement of both genes in 
eye development (Carson et al., 2004; Koshiba-Takeuchi et al., 2000; Leconte et al., 2004). 
In addition, TBX20 morphants appear to be defective in motor function, as 100% of Tbx20 
morpholino-injected embryos fail to exhibit swim reflexes in response to touch (data not 
shown). Embryos derived from injection of Tbx20 morpholinos directed against the antisense 
transcript, Tbx5 morpholinos containing mismatches, MOs directed against zebrafish Tbx5 
and Gene Tools, LLC’s MO control, gave no observable phenotype at any concentration 
(data not shown). These observations, and the findings that the TBX5 and TBX20 protein 
levels can be reduced or eliminated both in vitro and in vivo, suggest that the phenotypes we 
observe are specific for knocking down TBX5 and TBX20. 
 Tbx20 is expressed in the developing outflow tract and dorsal aorta progenitors 
(Brown et al., 2003; Szeto et al., 2002). Furthermore, Tbx5 is expressed in the developing 
common cardinal and hepatic veins (Fig. 3.4). Based on the expression of both genes in 
specific regions of the vasculature, I tested whether a loss of either protein results in loss of 
blood flow. Both TBX5 and TBX20 morphants display a lack of blood circulation at optimal 
morpholino doses (Fig. 3.5B, C), despite the retention of contractility in the cardiac tissue 
(data not shown). To examine blood flow in the double morphants I visualized the presence 
of blood using benzidine to detect hemoglobin. Similar to individual optimal injections, 
embryos coinjected with suboptimal doses of TBX5MO and TBX20MO exhibit a lack of 
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blood circulation despite the heart retaining contractility (Fig. 3.5D; data not shown). It 
should be noted that the heart defects become apparent well before the onset of circulation.  
Blood is still detected in these embryos, albeit at lower levels. Control embryos display 
prominent blood staining throughout the heart and vasculature, in contrast to TBX5, TBX20, 
and double morphants that do not show any blood staining in the heart. Furthermore, blood is 
seen to pool in the peri-anal region and gut region. The above results suggest that, in addition 
to the requirement for TBX5 and TBX20 individually in proper cardiogenesis and heart 
function, the combined activity of the two is also required for cardiac development, function, 
and blood circulation. 
To further define the requirements for Tbx5 and Tbx20 during cardiogenesis, we 
carried out a detailed analysis of TBX5MO and TBX20MO derived hearts relative to those 
from ControlMO injections. For these analyses, staged-matched TBX5MO, TBX20MO, and 
ControlMO embryos were collected at stage 37, serial sectioned and stained for the terminal 
differentiation markers tropomyosin and cardiac actin, and counterstained with DAPI (Fig. 
3.6). Results from this analysis clearly demonstrate that TBX5MO and TBX20MO derived 
hearts fail to undergo cardiac looping and chamber formation. In addition, quantification of 
total cardiac cell number by serial sectioning shows that both TBX5MO and TBX20MO 
hearts have a significant reduction in cell number compared to controls, and TBX20MO-
derived hearts have a significantly fewer cardiomyocytes than those from TBX5MO (Fig. 
3.6M).  
In addition to these defects we note some unique features to both the TBX5MO and 
TBX20MO derived hearts, most notably TBX5MO hearts remain as an open cardiac trough 
(Mohun et al., 2000) throughout development and fail to form a cardiac tube (Fig. 3.6E-H). 
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In contrast, TBX20MO derived embryos form a cardiac tube; however, the lumen often 
collapses and the hearts concomitantly show a dramatic decrease in the presence of cardiac 
actin (Fig. 3.6I-L). We also note a decrease in cardiac actin in TBX20MO-derived hearts 
(Fig. 3.6L) compared to TBX5MO or control hearts (Fig. 3.6D, H). Together this data 
demonstrates a requirement for both Tbx5 and Tbx20 in normal heart morphogenesis, and 
implies that TBX5 cannot compensate for the loss of TBX20, nor can TBX20 compensate for 
the loss of TBX5 and suggests that Tbx5 and Tbx20 play non-redundant roles during normal 
heart development.  
Analysis of hearts derived from TBX5MO and TBX20MO embryos shows a 
significant decrease in cardiac cell number. To determine if this is due to alterations in 
cardiac cell commitment, I performed whole-mount in situ hybridization with the early heart 
marker, Nkx2.5 (Fig. 3.7). This analysis was carried out on staged matched embryos derived 
from TBX5MO, TBX20MO and ControlMO embryos over the period of cardiac cell 
commitment and migration and differentiation (stages 16-36). I could detect no obvious 
difference in the number or spatial distribution of Nkx2.5-expressing cells prior to stage 24 
(Fig. 3.7). Consistent with initial analysis, after stage 24 the hearts from TBX5MO and 
TBX20MO embryos are morphologically abnormal and smaller in size, and therefore show a 
reduced domain of Nkx2.5 expression.    
The above results demonstrate that Tbx5 and Tbx20 are required for normal heart 
morphogenesis, but not for specification and migration of the cardiac precursors. To extend 
these findings, whole-mount in situ hybridizations were performed on stage 36 morphants 
and controls using the late heart markers atrial natriuretic factor (XANF; Small and Krieg, 
2000) and cardiac troponin I (XTnIc; Drysdale et al., 1994). As shown in Fig. 3.8, the 
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terminally differentiated cardiomyocyte marker XTnIc displays properly localized expression 
in the cardiac tissue of morphant embryos and appears to be expressed to the same degree, 
although due to the reduced cardiac mass it is expressed in fewer cells (Fig. 3.8D-F). XANF 
is a putative target of Tbx5, and its expression is reduced in the absence of Tbx5 in mice 
(Bruneau et al., 2001). In agreement with these findings, I show that Xenopus TBX5 activates 
transcription of a rat Nppa/ANF reporter plasmid (Fig. 3.10) and consistent with TBX5MO 
blocking TBX5, XANF expression is either greatly reduced or absent in TBX5 morphants, 
however, XANF is still detected in TBX20 morphants (Fig. 3.8A-C). These results indicate 
that terminal differentiation still occurs in both TBX5 and TBX20 morphant embryos and 
implies that XANF is an evolutionarily conserved target of TBX5. 
 
Tbx5 and Tbx20 are Not Dependent on Each Other’s Expression 
Since Tbx5 and Tbx20 are co-expressed within the heart and have similar 
requirements in heart development, I next asked whether Tbx5 and Tbx20 function linearly 
within the same molecular pathway. To address this question, I analyzed the expression of 
Tbx20 in TBX5MO-injected embryos and Tbx5 expression in TBX20MO-injected embryos. I 
could detect no differences in the expression of either gene in morpholino-injected embryos 
(Fig. 3.9); both genes remain expressed in the forming heart tissue, despite the reduction of 
cardiac tissue mass in morpholino-injected embryos. Based on these results we conclude 
TBX5 is not essential for Tbx20 expression, nor is Tbx20 dependent on TBX5.  
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TBX5 affects TBX20 transcriptional activity  
 My results strongly suggest that Tbx5 and Tbx20 do not function linearly within the 
same pathway yet have a similar requirement in heart development. We therefore carried out 
a series of experiments to test if TBX5 and TBX20 have either competing or complimentary 
functions at the molecular level. We first tested the cellular localization of TBX5 and 
TBX20. For these studies V5 epitope-tagged versions of the full-length cDNAs were 
transfected into NIH/3T3 cells. Immunohistochemistry on the transfected cells show that 
similar to TBX5 (Collavoli et al., 2003; Fan et al., 2003; Zaragoza et al., 2004), TBX20 is 
localized exclusively to the nucleus. (Fig. 3.10C-H)  
 We next tested if TBX5 and TBX20 can function to regulate the levels of 
transcription of the TBX5 target gene Nppa/ANF. To test for DNA specific binding and 
transcriptional activities, we transfected in full-length versions of Tbx5 and Tbx20, either 
alone or in combination, with the putative Tbx5 target Nppa/ANF reporter construct into 
293T cells. Consistent with studies using the mouse Tbx5 orthologue (Bruneau et al., 2001; 
Hiroi et al., 2001), TBX5 can weakly activate the rat Nppa/ANF reporter. In contrast, Tbx20 
alone can activate the Nppa/ANF in a dose dependent fashion. However, in the presence of 
TBX5, TBX20 can have the converse effect on the Nppa/ANF reporter. In the presence of 
TBX5, at high and low doses of TBX20 there is increased activation of the reporter 
construct, while at moderate doses there is a repressive effect (Fig. 3.10I). Thus, the presence 
of TBX5 appears to alter TBX20 transcriptional activity. 
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TBX5 and TBX20 physically interact with one another 
 Given the similarity in phenotypes of TBX5 and TBX20 morphant embryos, and the 
observation that Tbx5 and Tbx20 are not dependent on one another’s expression, I next 
assessed whether TBX5 and TBX20 can physically interact. TBX5 fused to Glutathione-S-
Transferase (GST) was incubated with HA-tagged TBX20 or NKX2-5. Pulldown 
experiments were then performed to assess whether TBX20 can bind to TBX5. NKX2-5 has 
been shown to interact with TBX5 and thus serves as a positive control (Bruneau et al., 2001; 
Hiroi et al., 2001). As shown in Fig. 3.11A, bacterially translated GST-TBX5 is able to bind 
HA-TBX20 and HA-NKX2-5 produced from 293T cells, in contrast to GST alone, which 
does not bind either protein. These results reveal that TBX5 and TBX20 can interact in vitro. 
This is the first report of physical interaction between T-box proteins. 
 Having demonstrated that TBX5 and TBX20 interact, I next mapped the interaction 
domains of TBX5 and TBX20. To this end, I constructed a deletion series of both GST-
tagged TBX5 and HA-tagged TBX20. As shown in Fig. 3.11B, GST-TBX5 proteins lacking 
the C-terminus still bind HA-TBX20, however when the small N-terminus and T-box domain 
are removed from GST-TBX5, HA-TBX20 fails to bind. Thus, the domain responsible for 
TBX20 binding lies within the N-terminus and T-domain of TBX5. Similarly, a C-terminal 
deletion of HA-TBX20 still binds to GST-TBX5, in contrast to deletions of the HA-TBX20 
N-terminus and T-domain (Fig. 3.11C). As seen in the ∆N/C lane in Fig. 3.11E, the HA-
TBX20 deletion containing only the T-box domain did not bind GST-TBX5. However, we 
were unable to obtain comparable amounts of the HA-T20-∆N/C protein, as seen in the input 
lane. This could be due to mRNA or protein instability. In an attempt to circumvent this 
problem, the amount of HA-T20-∆N/C protein incubated with GST-TBX5 was increased 2-
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fold as compared to the rest of the experiments.  These results indicate that the N-terminus 
and possibly the T-domain of TBX20 are required for its interaction with TBX5, although we 
cannot rule out the possibility that the amount of HA-T20-∆N/C protein was insufficient to 
identify a requirement for the T-domain. In summary, my results reveal that the domains 
responsible for the interaction between TBX20 and TBX5 map to within the N-terminal and 
T-box domains in both proteins. 
 
Tbx5 and Tbx20 cooperate to regulate heart morphogenesis 
 Given that TBX5 and TBX20 physically interact with one another, I hypothesized 
that Tbx5 and Tbx20 may function cooperatively to control cardiogenesis. To test this 
hypothesis, I coinjected concentrations of TBX5MO and TBX20MO below the threshold at 
which cardiac phenotypes are efficiently induced when injected individually. At a 
concentration of 40 ng per embryo for Tbx5 morpholinos and 80 ng per embryo for Tbx20 
morpholinos, injections yield consistent heart phenotypes in 82% of TBX5MO-injected 
embryos and in 100% of TBX20MO-injected embryos (Fig. 3.3). I refer to this dose as the 
“optimal” dose, because it is the dose hat efficiently blocks translation of TBX5 and TBX20 
in vivo (Fig. 3.1 D, E) and the dose that gives efficient and penetrant cardiac phenotypes. At 
half doses, 20 ng per embryo for TBX5MO and 40 ng per embryo for TBX20MO, each 
morpholino yields significantly fewer and weaker heart phenotypes compared to the full dose 
(Fig. 3.12M, data not shown). I refer to this concentration as the “suboptimal” dose for 
inducing cardiac defects. The terms “optimal” and “suboptimal” are only used to refer to the 
concentrations that yield fully penetrant or partially penetrant cardiac phenotypes, 
respectively.  
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To address the question of whether Tbx5 and Tbx20 cooperate in cardiogenesis, I 
injected TBX5MO and TBX20MO individually at suboptimal doses in combination with 
ControlMO to keep total morpholino concentrations equal in all injections. TBX5MO was 
then coinjected with TBX20MO, each at the suboptimal dose. ControlMO injected at 
80ng/embryo served as control. As shown in Figure 3.12, only 4% of embryos injected with 
suboptimal TBX5MO/ControlMO displayed pericardial edema, unlooped heart tubes, and 
reduction in cardiac mass. Suboptimal TBX20MO/ControlMO yields only 13% cardiac 
defects. In suboptimal injections, the majority of embryos appeared normal, while the few 
cardiac phenotypes produced were much less severe than at optimal doses (e.g. barely 
detectable reduction in cardiac mass, slight perturbation of looping and little or no pericardial 
edema). When coinjected at suboptimal doses, 74% of TBX5MO/TBX20MO coinjected 
embryos display dramatic cardiac defects compared to 0% of ControlMO-injected embryos 
(Fig. 3.12D, H, L). The observation that the percentage of heart defects in double morphants 
is more than additive suggests that Tbx5 and Tbx20 synergistically act to control heart 
morphogenesis. 
 If Tbx5 and Tbx20 cooperate to regulate cardiogenesis, one might expect a more 
severe alteration in cardiac morphology and marker expression when the levels of both 
proteins are reduced. To address this question I performed in situ hybridizations on stage 36 
embryos from the above double injection experiment using Nkx2-5, XANF, and XTnIc 
probes. As shown in Figure 3.12, all three markers are expressed normally in embryos 
injected with suboptimal doses of TBX5MO and TBX20MO as compared to ControlMO. 
However, heart marker expression in the double morphant embryos is markedly reduced, 
particularly XANF. Both Nkx2-5 and XTnIc are still detectable in the heart region, albeit in 
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fewer cells. Thus, the synergistic cooperation of TBX5 and TBX20 are required for proper 
heart development. 
 
D.  Discussion 
 Members of the T-box family of proteins play a fundamental role in patterning the 
developing vertebrate heart, however, the precise cellular requirements for any one family 
member remains largely unknown. In this study, I demonstrate that TBX5 and TBX20 are 
both required for early cardiac morphogenesis. Moreover, I show that TBX5 and TBX20 
function in the same pathway implying a synergistic role for these two proteins during early 
heart development. Consistent with this proposal, I show that TBX5 and TBX20 can 
physically and functionally interact, therefore providing the first evidence for direct 
interaction between members of the T-box gene family.  
 
Functions of Tbx5 and Tbx20 in Cardiac Morphogenesis 
 Our studies show that Tbx5 and Tbx20 are required for similar cellular processes in 
the developing heart. This data demonstrates a non-redundant function for TBX5 and TBX20 
during cardiac morphogenesis; neither protein can compensate for the other in heart 
morphogenesis.  The lack of redundancy at the molecular level is corroborated by the 
observation that the putative TBX5 target gene XANF either is not expressed or is expressed 
very weakly in TBX5 morphant embryos, while being expressed at the proper time, place and 
levels in TBX20 morphant embryos.  Together this data suggests that TBX5 and TBX20 act 
in a non-redundant fashion to control morphogenetic movements of early heart tissue.  
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The cardiac defects in response to a reduction of either TBX5 or TBX20 appear to 
represent a block in an early morphological step in heart formation. Since the spatial 
distribution of Nkx2.5 is unaltered throughout early development in TBX5MO, TBX20MO 
and ControlMO injected embryos, and since Nkx2.5, Tbx5, and Tbx20 continue to be 
expressed until the later stages of heart development, and TBX5 and TBX20 morphants 
express markers of terminal muscle differentiation, neither Tbx5 nor Tbx20 appear to be 
required for commitment, migration or terminal differentiation of cardiac tissue. Thus, both 
Tbx5 and Tbx20 appear to be required to direct the coordinated events that occur during the 
early steps of heart morphogenesis.  
Consistent with this hypothesis, both TBX5 and TBX20 morphant hearts are greatly 
extended along the anterior-posterior axis, and the heart tube fails to correctly loop and 
undergo chamber formation. As a result, embryos display pericardial edemas, have impaired 
blood flow (Fig. 3.5), an irregular heartbeat (data not shown) and ultimately die. Thus, the 
alteration in heart morphology appears to be the primary outcome of perturbing TBX5 or 
TBX20 function.  
Past attempts to interfere with Tbx5 function in X. laevis were carried out by the 
misexpression of a putative interfering form of Tbx5 that leads to either the absence or severe 
malformations of the heart (Horb and Thomsen, 1999). In instances in which the heart does 
form, there is a reduction or block in myocardial tissue formation and a failure of the heart to 
undergo looping. My results with Tbx5-specific morpholinos show a less severe heart 
phenotype than those reported with the dominant interfering Tbx5 but bear a close 
resemblance to those reported for the zebrafish Tbx5 mutant, heartstrings (Garrity et al., 
2002). This may be due to the dominant-interfering form of Tbx5 used in the X. laevis studies 
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interfering with the function of both Tbx5 and Tbx20 or possibly other T-box family 
members expressed in the developing heart, e.g. Tbx1 and Tbx2 (Chapman et al., 1996b), as 
has been shown for other Engrailed fusions (Horb and Thomsen, 1997). However, in the 
absence of a TBX5 specific antibody, we cannot formally rule out the possibility that some 
residual TBX5 protein is present in morphant embryos leading to a less severe phenotype in 
our studies. 
 
Tbx5 and Tbx20 are Not Dependent on One Another’s Function 
 The phenotypes of TBX5 and TBX20 morphant embryos do not appear to act in a 
linear pathway since the spatial and temporal expression of Tbx5 appears unaltered in TBX20 
morphants, and vice versa. These findings are in agreement with studies showing normal 
expression of Tbx20 in Tbx5 mutant mice (Stennard et al., 2003) but in apparent conflict with 
a second study reporting the downregulation of Tbx5 in zebrafish embryos injected with a 
Tbx20 morpholino (Szeto et al., 2002). Although the zebrafish and X. laevis orthologues of 
Tbx20 share a very high degree of identity at the protein level (86%), the differences between 
the two orthologues may reflect a species difference as, for example, has been reported for 
the endodermal-inducing activities of the T-box-containing gene Brachyury (Marcellini et al., 
2003). Although no alterations in Tbx5 or Tbx20 RNA levels were observed in morphant 
embryos, I did observe a downregulation of TBX5 protein in response to Tbx20 morpholinos 
in vivo, and vice versa, but not in vitro (Fig. 3.1), raising the interesting possibility that cross-
regulation may be occurring between TBX5 and TBX20 at the level of translation. Since 
similar studies have not been conducted in zebrafish, it is not possible at this time to know 
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the mechanisms of cross-regulation or if this is a conserved response to interfering with 
TBX5 or TBX20.   
  
TBX5 and TBX20 Heterodimerization 
 Although Tbx5 and Tbx20 are coexpressed and both function in early heart 
development, the genes appear to be regulated through separate pathways. For example, 
Tbx20 but not Tbx5 can be induced in response to BMP2 signaling (Plageman and Yutzey, 
2004). Taken together with my results demonstrating a physical interaction between TBX5 
and TBX20, these data would suggest that TBX5 and TBX20 function in parallel pathways 
that converge upon TBX5:TBX20 heterodimerization. This model is also supported by my 
results showing a functional interaction between TBX5 and TBX20; embryos derived from 
injections of suboptimal doses of Tbx5 and Tbx20 morpholinos have only minor effects on 
heart development in a small proportion of the embryos. However, when injected in 
combination 74% of all embryos examined displayed grossly abnormal heart formation. 
 What are the possible cellular functions of TBX5 and TBX20 in heart development? 
Past studies on T-box genes have shown a direct link between members of the T-box gene 
family and cell adhesion. For example, embryos homozygous for mutations in Brachyury, the 
founding member of the T-box gene family, show an inability of the mesoderm to properly 
migrate along the extracellular matrix leading to an inability of the mesodermal germ layer to 
complete the morphogenetic movements normally associated with gastrulation (Showell et 
al., 2004). An analogous model for TBX5 and TBX20 function may include regulation of 
cell polarity or adhesion events associated with heart morphogenesis. It is possible that TBX5 
and TBX20 function to control polarity or adhesive properties of cardiac tissue once the two 
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heart fields merge along the anterior midline, and that target specificity is regulated through 
TBX5 and TBX20 protein-protein interactions. It is also possible that TBX5 and TBX20 may 
work in concert to regulate cell division and proliferation. In agreement with this proposal, 
we have recently shown that alterations in cardiac cell numbers, survival and proliferation in 
TBX5MO-derived embryos are a consequence of disrupting TBX5 function (Goetz et al., 
2006).  
 It is worth noting that neither TBX5 nor TBX20 have strong transcriptional activation 
or repression activity by themselves (Fig. 3.10; Bruneau et al., 2001; Hiroi et al., 2001; 
Plageman and Yutzey, 2004; Stennard et al., 2003). Thus, transcriptional activity appears to 
be governed by protein-protein interactions. Past studies have identified several other 
interacting partners for both TBX5 and TBX20. For example, both TBX5 and TBX20 have 
been shown to interact with the homeobox-containing transcription factor NKX2-5 (Bruneau 
et al., 2001; Hiroi et al., 2001; Stennard et al., 2003), consistent with clinical studies showing 
that HOS patients and humans heterozygous for NKX2-5 display many of the same cardiac 
defects (Elliott et al., 2003; Goldmuntz et al., 2001; Prall et al., 2002).  
How might TBX5:TBX20 heterodimerization affect target choice? It may be that the 
role of TBX5:TBX20 dimerization is to sequester TBX5 and thereby block its interaction 
with other proteins such as NKX2.5 thereby indirectly inhibiting the induction of cardiac 
specific genes such as XANF. However, several lines of evidence argue against such a 
proposal. For example, at low and high concentrations TBX20 can increase transcription of 
the Nppa/ANF reporter in the presence of TBX5, while showing a repressive activity at 
intermediate concentrations, suggesting that in certain contexts TBX20 can cooperate with 
TBX5 to activate transcription, while antagonizing TBX5 activity in others.  An alternative 
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possibility is that TBX20 target choice and ability to function as a transcriptional activator or 
repressor is governed by its choice of interacting partners. Consistent with this hypothesis, 
Stennard et al (2003) have shown that NKX2.5, GATA4, and GATA5 interact with TBX20, 
and the interactions occur through the same domain of TBX20 that we have shown interacts 
with TBX5, at least in the cases of NKX2.5 and GATA4 (Stennard et al., 2003). 
Furthermore, the authors demonstrated that TBX20 can repress synergistic activation of a 
connexin 40 reporter by NKX2.5 and GATA4, while synergistically activating the same 
reporter with NKX2.5 and GATA5. Thus, TBX20 may be able to function both as a 
transcriptional activator or repressor, and this decision is based on its choice of protein 
partners.  In addition, TBX5 and TBX20 have been shown to display different binding 
affinities for different T-box binding sites (Stennard et al., 2003). For example, TBX20 
unlike TBX5 can bind to the Brachyury target site while TBX5 has a higher affinity than 
TBX20 for the T-box binding site in the Nppa/ANF promoter. Thus, downstream target 
selection may be dictated by homodimerization verses heterodimerization. This is supported 
by the recent findings that several genes involved in heart development are found to contain 
multiple T-box binding sites (R. Schwartz personnel communication, FLC unpublished 
findings). Our model would suggest that TBX5 and TBX20 target selection and 
transcriptional activity is based on partner choice in a specific tissue at a specific time. 
However, it still remains to be established which protein interactions take place in the 
developing heart and in turn, what governs the choice of partners for TBX5 or TBX20.  
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Figure 3.1.  Tbx5 and Tbx20 morpholinos block translation of their respective target 
proteins.  
(A) TBX5MO and TBX20MO positions relative to Tbx5 and Tbx20 cDNA. (B) Inhibition of 
TBX5-V5 translation in vitro by TBX5MO.  TBX20MO and ControlMO serve as controls. 
Each reaction contains 1 µg of Tbx5-V5 circular plasmid along with the indicated amounts of 
MO.  (C) Inhibition of TBX20-V5 translation in vitro by TBX20MO.  TBX5MO and 
ControlMO serve as controls. Each reaction contains 1 µg of Tbx20-V5 circular plasmid 
along with the indicated amounts of MO. (D) Inhibition of TBX5-V5 translation by 
TBX5MO in animal caps. TBX20MO and ControlMO serve as controls. Probed with anti-V5 
and re-probed with anti-PTP1D/SHP2 as a loading control. Embryos injected with 2 ng 
mRNA and the indicated amounts of MO. (E) Inhibition of TBX20-V5 translation by 
TBX20MO in animal caps. TBX20MO and ControlMO serve as controls. Probed with anti-
V5 and re-probed with anti-PTP1D/SHP2 as a loading control. Embryos injected with 2 ng 
mRNA and the indicated amounts of MO. 
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Figure 3.1.  Tbx5 and Tbx20 morpholinos block translation of their respective target 
proteins. 
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Figure 3.2. Sequence alignments suggest that Tbx5 and Tbx20 morpholinos cannot cross 
react. 
(A) Alignments of Tbx5 morpholinos (complementary sequence) with Tbx5 and Tbx20 
mRNA sequence. (B) Alignments of Tbx20 morpholinos (complementary sequence) with 
Tbx5 and Tbx20 mRNA sequence. 
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Figure 3.2. Sequence alignments suggest that Tbx5 and Tbx20 morpholinos cannot cross 
react. 
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Figure 3.3. Tbx5 and Tbx20 are required for proper cardiogenesis.  
(A-F) Morpholino-injected tadpoles at the indicated stages. Control morphant embryos (A, 
D), TBX5 morphant embryos (B, E), TBX20 morphant embryos (C, F). Arrows indicate the 
heart region, arrowheads indicate the eye. (G) Chart displaying the percentage of morphants 
surviving and displaying cardiac abnormalities as scored by the presence of an unlooped 
heart tube, a reduction in cardiac mass and the presence of a pericardial edema. 
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Figure 3.3. Tbx5 and Tbx20 are required for proper cardiogenesis. 
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Figure 3.4. Tbx5 is expressed in the common cardinal and anterior hepatic veins. 
(A, B) Whole mount in situ hybridization of Xenopus embryos at stage 36 (A) and 42 (B). 
Parasaggital section show expression in the myocardium (m), endocardium (e), and 
pericardium (p). (C, D) Oblique sections through a stage 36 embryo showing expression in 
the common cardinal (cc) and anterior hepatic veins (h). 
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Figure 3.4. Tbx5 is expressed in the common cardinal and anterior hepatic veins. 
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Figure 3.5. Tbx5 and Tbx20 morpholinos block the formation of a functional heart as 
assayed by benzidine staining of erythrocytes in stage 42 tadpoles.  
(A) Uninjected control, (B) TBX5MO injected at optimal dose, (C) TBX20MO injected at 
optimal dose, (D) TBX5MO and TBX20MO injected together at suboptimal doses. Note: 
Blood staining in the heart region (h) of control embryos but not morphant embryos. 
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Figure 3.5. Tbx5 and Tbx20 morpholinos block the formation of a functional heart as 
assayed by benzidine staining of erythrocytes in stage 42 tadpoles. 
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Figure 3.6. TBX5 and TBX20 morphants fail to undergo looping and chamber 
formation and display reduced cardiac cell numbers.  
Cryosections of TBX5 and TBX20 morphant hearts taken at the anterior (outflow), middle 
(ventricular), and posterior (atrial) regions. (A-D) ControlMO, (E-H) TBX5MO, and (I-L) 
TBX20MO.  Sections stained for tropomyosin (red), DAPI (blue), and cardiac actin (green). 
(D, H, L) Same sections as B, F, and J stained with cardiac actin. Note that in the looped 
control heart, the middle ventricular section also contains the atrium. (M) Mean number of 
cells per hearts obtained by cell counts of heart tissue in serial sections of derived from a 
minimum of three embryos. 
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Figure 3.6. TBX5 and TBX20 morphants fail to undergo looping and chamber 
formation and display reduced cardiac cell numbers. 
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Figure 3.7. Cardiac specification is unaltered in TBX5 and TBX20 morphants.  
Whole-mount in situ hybridization with Nkx2.5 on stage matched (A, D, G, J) ControlMO-, 
(B, E, H, K) TBX5MO-, or (C, F, I, L) TBX20MO-derived embryos. 
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Figure 3.7. Cardiac specification is unaltered in TBX5 and TBX20 morphants. 
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Figure 3.8. TBX5 and TBX20 morphants display dramatic morphological defects. 
Whole-mount in situ hybridizations of cleared stage 36 embryos. (A-C) ANF whole mount in 
situ hybridization. (D-F) XTnIc whole mount in situ hybridization. (A, D) ControlMO. (B, 
E), TBX5MO, (C, F) TBX20MO. 
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Figure 3.8. TBX5 and TBX20 morphants display dramatic morphological defects. 
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Figure 3.9.  Tbx5 and Tbx20 are localized to the nucleus and can activate transcription 
on the Nppa/ANF promoter. 
(A) Schematic depicting the amino acid positions of the T-box domains of Tbx5 and Tbx20. 
(B) Schematic of Rat Nppa/ANF-luciferase reporter construct showing T-box binding site 
consensus sequences and their relative position within the promoter relative to translation 
start site. (C, F) Transfected cells were stained with anti-V5 (Cy2, green) for TBX5-V5 and 
TBX20-V5 and (D, G) anti-phosphotyrosine (Cy3, red) to visualize cytoplasmic 
compartment. (E, H) Overlay image of Cy2 and Cy3 staining. (I) Rat ANF-luciferase co-
transfected with a constant amount of Tbx5 (100 ng) and increasing amounts of Tbx20 (25, 
50, 100 and 500 ng) in 293T cells and level of transcriptional activation expressed as 
Relative Luciferase Units based on average of three independent experiments performed in 
triplicate. 
 
 80
Figure 3.9.  Tbx5 and Tbx20 are localized to the nucleus and can activate transcription 
on the Nppa/ANF promoter. 
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Figure 3.10. Tbx5 and Tbx20 are not required for each other’s expression. 
Embryos injected at the one-cell stage with ControlMO, TBX5MO, or TBX20MO. (A, C) 
Whole-mount in situ hybridization showing Tbx5 expression. (B, D) Whole-mount in situ 
hybridization showing Tbx20 expression. 
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Figure 3.10. Tbx5 and Tbx20 are not required for each other’s expression. 
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Figure 3.11. TBX5 and TBX20 can physically interact. 
Cell lysates containing GST- and/or HA-tagged proteins were incubated on GST and eluted, 
and separated by SDS-PAGE. GST proteins were detected using anti-GST antibodies and 
HA-tagged proteins were detected with anti-HA antibodies. (A) Association of TBX5 with 
TBX20 is shown by pulldown of HA-TBX20 with GST-TBX5. HA-NKX2-5 serves as 
positive control. 15% of output and 7.5% of input was probed. (B, C) Pulldown of full-length 
HA-TBX20 with a GST-tagged TBX5 deletion series reveals an interaction domain in the N-
terminus and T-box region of TBX5. Each reaction was probed with anti-HA antibodies. 
7.5% of input and 15% of output was probed. (D, E) Pulldown of HA-TBX20 deletion series 
with full-length GST-TBX5 reveals an interaction domain within the N-terminus and T-box 
of TBX20. Each reaction was probed with anti-HA antibodies. 7.5% of input and 15% of 
output was probed, except in the case of ∆N/C in which the amount of protein probed was 
only 4% due to the increase in total amount of ∆N/C protein used in pulldown (see text). 
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Figure 3.11. TBX5 and TBX20 can physically interact. 
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Figure 3.12. Tbx5 and Tbx20 synergistically act to regulate cardiac gene expression. 
(A-L) Embryos injected with the indicated morpholinos at the one-cell stage. (A-D) Nkx2-5 
whole mount in situ hybridization. (E-H) XANF whole mount in situ hybridization. (I-L) 
XTnIc whole mount in situ hybridization. (A, E, I) ControlMO, (B, F, J) TBX5MO injected 
at suboptimal dose, (C, G, K) TBX20MO injected at suboptimal dose, (D, H, L) TBX5MO 
and TBX20MO injected in combination at suboptimal doses. All embryos were cleared to 
reveal heart expression. (M) Statistics for embryos injected with suboptimal doses of 
TBX5MO and TBX20MO in combination with each other or with ControlMO. Hearts were 
judged as having defects if they displayed a pericardial edema, an unlooped heart tube, or 
reduction in cardiac mass. 
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Figure 3.12. Tbx5 and Tbx20 synergistically act to regulate cardiac gene expression. 
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CHAPTER IV 
A MICROARRAY-BASED SCREEN FOR TARGETS OF TBX20 AND TBX5 
FUNCTION 
A.  Introduction 
 Work from our lab and others has demonstrated that both Tbx5 and Tbx20 function 
are required for proper cardiac morphogenesis (Chapter III; Brown et al., 2005; Bruneau et 
al., 2001; Cai et al., 2005; Garrity et al., 2002; Horb and Thomsen, 1999; Stennard et al., 
2005; Takeuchi et al., 2005). Despite the known requirements for these transcription factors 
in heart development, very few direct targets of their transcriptional activity have been 
identified. Tbx5 has been shown to directly bind to elements within the promoters of 
connexin40 (cx40) and atrial natriuretic factor (ANF; Bruneau et al., 2001; Ghosh et al., 
2001). Furthermore, TBX5 has been shown to bind the consensus Brachyury (T) T-box 
binding element (TBE) in vitro (Ghosh et al., 2001).  However, it is unknown whether other 
targets exist for TBX5 function or whether these targets contain consensus TBEs or different 
binding elements.  Recently, TBX20 was shown to bind to the promotor of Tbx2, resulting in 
repression of Tbx2 expression (Cai et al., 2005).  In addition, TBX2 was itself shown to bind 
to the promoter of Nmyc1, a regulator of cell proliferation (Cai et al., 2005).  Binding of 
TBX2 to the Nmyc1 promoter was further shown to inhibit Nmyc1 expression, resulting in a 
reduction of cardiomyocyte proliferation (Cai et al., 2005). These results suggest a possible 
explanation for the cardiac defects apparent in embryos depleted for TBX20; loss of TBX20 
  
results in a de-repression of Tbx2, in turn leading to repression of cell proliferation by TBX2 
activity on Nmyc1. Thus, studies have resulted in the identification of only two direct targets 
of TBX5 activity and one target of TBX20 activity. 
 Since the putative targets of TBX20 and TBX5 are reported to act during chamber 
formation, and thus, at later stages of heart development than the stages at which we have 
reported TBX20 and TBX5 to function in morphogenesis, we sought to identify early targets 
of these transcription factors (Chapter III; Brown et al., 2005; Bruneau et al., 2001; Cai et al., 
2005; Ghosh et al., 2001). To this end we here report a microarray-based screen for genes 
misregulated in response to loss of TBX20 or TBX5. These results have yielded two sets of 
genes misregulates in TBX20 and TBX5 morphant embryos, providing the basis for future 
studies. We demonstrate that a subset of cell cycle regulators are misregulated in Tbx5 
morphant embryos. In addition, we report the identification of several novel cardiac-specific 
genes, including the Xenopus orthologues of titin novex-3 (Xtn3) and heat shock protein 27 
(XHsp27). 
 
B.  Materials and Methods 
Microarray Assay 
 7 µg of total RNA was used to synthesize cDNA.  A custom cDNA kit from Life 
Technologies was used with a T7-(dT)24 primer for this reaction.  Biotinylated cRNA was 
then generated from the cDNA reaction using the BioArray High Yield RNA Transcript Kit.  
The cRNA was then fragmented in fragmentation buffer (5X fragmentation buffer: 200mM 
Tris-acetate, pH8.1, 500mM KOAc, 150mM MgOAc) at 94oC for 35 minutes before the chip 
hybridization.  15 µg of fragmented cRNA was then added to a hybridization cocktail (0.05 
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µg/µl fragmented cRNA, 50 pM control oligonucleotide B2, BioB, BioC, BioD,  and cre 
hybridization controls, 0.1 mg/ml herring sperm DNA, 0.5 mg/ml acetylated BSA, 100mM 
MES, 1M Na+, 20mM EDTA, 0.01% Tween 20). 10 µg of cRNA was used for hybridization.  
Arrays were hybridized for 16 hours at 45oC in the GeneChip Hybridization Oven 640.  The 
arrays were washed and stained with R-phycoerythrin streptavidin in the GeneChip Fluidics 
Station 400.  After this, the arrays were scanned with the Hewlett Packard GeneArray 
Scanner.  Affymetrix GeneChip Microarray Suite 5.0 software was used for washing, 
scanning, and basic analysis.  Sample quality was assessed by examination of 3’ to 5’ 
intensity ratios of certain genes. 
 
Whole-mount RNA in situ Hybridization 
 Briefly, each EST clone was obtained from either OpenBiosystems for I.M.A.G.E. 
clones or from the National Institute for Basic Biology (Japan) for all others. Known genes 
were obtained as follows. Ath5a (generous gift from M Vetter; Kanekar et al., 1997), Mmp9 
(kind gift from J. Henry; Carinato et al., 2000)), tropomyosin beta 44 (Tmb44; generous git 
of P.Thiebaud; Hardy and Thiebaud, 1992), and Vent2 (generous gift from J. Gurdon; Ladher 
et al., 1996). Whole-mount in situ hybridizations were performed as previously described 
(Harland, 1991). 
 
C.  Results 
 In order to identify genes downstream of TBX20 and TBX5 function, we initiated a 
microarray-based screen for genes misregulated in TBX20- and TBX5-depleted embryos.  
We used the Affymetrix Xenopus GeneChip, which consists of ~14,400 transcripts and 
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15,503 features. Approximately 3500 known genes, constituting all named X. laevis 
transcripts at manufacturing time are included on the microarray. Each probe on the chip is 
25 nucleotides in length and each feature consists of 16 random probes. Furthermore, control 
features containing mismatch reference probes for each probe set are inluded on the 
microarray. Sequences on the array were selected from the several public data sources, 
including GenBank (release 135.0, April 2003), dbEST (June 2003), and UniGene (build 36, 
June 2003). Briefly, embryos were injected at the one-cell stage with either 60ng TBX20MO, 
40ng TBX5MO, or 60ng ControlMO, and allowed to develop to stage 26, prior to observable 
cardiac defects in morphant embryos (Chapter III; Brown et al., 2005)).  The anterior 1/3 of 
each embryo was then dissected to enrich for cardiac-specific genes and collected for total 
RNA isolation. For each treatment, 40 embryos were pooled for RNA isolation and this was 
performed in triplicate, resulting in three RNA samples for each treatment.  Furthermore, the 
entire experimental procedure was performed twice for the Tbx20 morphant microarray, 
totalling six samples for each treatment. 
 Statistical analysis of the microarray data was performed using GeneChip Microarray 
Suite 5.0 (Affymetrix) and GeneSpring microarray analysis software (Agilent Technologies). 
Hybridization of total RNA to the microarrays and initial processing of raw data was 
performed by the UNC Functional Genomics Core Facility (see materials and methods). The 
intensity reading for each feature was normalized to the mismatch reference feature for each 
probe set. In order to narrow down the putative list of misregulated targets, a minimum of 2-
fold change in expression was used as a selection criterion. The list of genes misregulated at 
least 2-fold was further culled by analysis of variance (ANOVA) tests to identify genes that 
were significantly misregulated at least 2-fold at a significance value of p≤0.05. 
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 Depletion of TBX20 resulted in the identification of 45 transcripts significantly 
misregulated at least 2-fold (Table 4.1). The vast majority of these transcripts were found to 
be uncharacterized ESTs, with only 4 transcripts, atonal homologue 5a (Ath5a), matrix 
metalloprotease 9 (Mmp9), tropomyosin beta 44 (Tmb44), and Vent2, having been previously 
cloned and annotated (Carinato et al., 2000; Hardy and Thiebaud, 1992; Kanekar et al., 1997; 
Ladher et al., 1996). In order to corroborate the misregulation of these transcripts, a 
secondary screen by whole-mount in situ hybridization was performed. Briefly, Tbx20MO or 
ControlMO were injected at the one-cell stage and embryos were collected at neurula stage 
(stage 19), early tailbud stage (stage 26), or late tailbud stage (stage 36).  Ten embryos at 
each stage, for each treatment, and for each probe were collected and submitted to whole-
mount in situ hybridization, totalling 2700 embryos, 45 probes, 3 stages per treatment, and 2 
treatments.  Despite the observation that transcripts were found to be misregulated in a range 
from 16-fold downregulated to 10-fold upregulated as assayed by microarray, none of the 
probes showed significant or obvious misregulation by whole-mount in situ hybridization 
(Table 4.1; data not shown). This may be due to the lack of sensitivity inherent in whole-
mount in situ hybridization analysis. However, 27% of the transcripts were found to be 
specifically expressed in developing cardiac tissue, in corroboration with our findings that a 
defect in cardiogenesis is a primary phenotype of TBX20 depletion (Table 4.1; Chapter III). 
One of these ESTs, EST25, was found to be dramatically expressed throughout developing 
cardiac and skeletal muscle. This transcript was subsequently sequenced and characterized, 
resulting in the identification of the X. laevis orthologue of titin novex 3 (Xtn3; see Chapter 
V).  
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 In order to identify genes involved in cardiogenesis and putatively downstream of 
TBX20 function, we undertook a candidate-approach to identify the unknown ESTs that 
were both expressed in the developing heart and contained full-length sequences against 
which we could design antisense morpholino oligonucleotides. By this method we found that 
EST31 contains a full-length cDNA, including 5’ UTR, 3’ UTR, and polyA tail. The 
sequence, expression, and requirement for this transcript was subsequently characterized, 
resulting in the identification of Hsp27 as a critical regulator of cardiac progenitor fusion and 
actin cytoskeletal dynamics (see Chapter VI).  
 Results from depletion of TBX5 yielded a list of 303 genes misregulated in response 
to loss of TBX5 protien.  Forty nine of these transcripts appear to be involved with cell-cycle 
regulation (Table 4.2). These results have led to a subsequent study performed  by Sarah 
Goetz in which she has demonstrated that a subset of cell cycle regulators expressed in S 
phase of the cell cycle are misregulated in response to loss of TBX5 (Goetz et al., 2006). We 
did not observe overlap between genes misregulated in response to loss of TBX20 or TBX5, 
suggesting that the loss of either TBX20 or TBX5 is insufficient to induce a 2-fold change of 
targets on which both factors act. Alternatively, it may be that perhaps only one gene or a 
few genes are targeted by both TBX20 and TBX5 and these genes were not present on the 
microarray. Further analysis of genes misregulated in response to loss of TBX5 is ongoing by 
F. Conlon and colleagues. 
 
D.  Discussion 
 In the present study I have identified a large number of genes putatively misregulated 
in response to loss of either TBX20 or TBX5 protein using microarray analysis. The majority 
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of transcripts misregulated at least 2-fold were found to consist of previously unknown ESTs. 
However, secondary screening by whole-mount in situ hybridization reveals that 27% of the 
transcripts misregulated by TBX20 depletion are expressed in the developing heart, 
suggesting that the misregulation is in fact due to loss of Tbx20 or to indirect effects on 
cardiogenesis by TBX20 depletion. Unfortunately, significant misregulation of these ESTs 
could not be validated via whole-mount in situ hybridization, suggesting either that these 
targets are not bona fide downstream targets of TBX20 function, or that the screening 
method is not sensitive enough to detect the difference in expression. However, results from 
the concurrent screen for targets of TBX5 function identified a large number of genes 
involved in cell cycle regulation to be putatively downstream of TBX5. These results were 
followed up in a collaboration with Sarah Goetz, in which she demonstrated that a subset of 
genes involved in S-phase prgression are misregulated in TBX5-depleted embryos (Goetz et 
al., 2006). These findings suggest that at least a portion of targets identified by microarray 
analysis are downstream of TBX5 function. Considering that both the TBX20 and TBX5 
experiments were performed at the same time, using the same batch of microarrays, and the 
same batch of embryos, the above results support the validity of the microarray data and 
suggest that the method of secondary screening used for TBX20 target validation is 
insufficent. An ideal secondary screen would involve performing chromatin 
immunoprecipitation and microarray analysis (ChIP-on-chip) by immunoprecipitating 
TBX20 and the genomic sequences bound by TBX20, followed by hybridization of the co-
precipitated DNA to a genomic microarray. Unfortunately, highly-specific TBX20 antibodies 
are currently unavailable. Furthermore, only ~3500 genes are currently known in X. laevis, 
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and the X. tropicalis genome is only partially annotated, thus complicating this potential 
technique. 
 While in situ hybridization has not yielded insights into whether particular putative 
targets are directly downstream of TBX20 function, these data have resulted in the 
identification of several novel transcripts expressed in the developing heart, and thus 
potentially involved in cardiogenesis (Table 4.1). In collaboration with Anna Davis, I have 
sequenced one of these ESTs (EST25; Table 4.1) and characterized its expression within 
developing cardiac and skeletal muscle, thus identifying the X. laevis orthologue of novex 
titin-3 (XTn3; Chapter V). In addition, we sought to identify putative targets that result in 
cardiac phenotypes when depleted by antisense morpholinos (Chapter IV). These results led 
to the identification of X. laevis heat shock protein 27 (XHsp27) as being expressed n 
developing cardiac and skeletal muscle, and demonstrated a requirement for XHSP27 
function in cardiac precursor fusion (Chapter VI). Thus, microarray analysis of TBX20 and 
TBX5 depletion has resulted in the demonstration of TBX5 function in cell cycle regulation, 
the identification of XHsp27 as being critical for proper cardiogenesis, as well as the 
identification of a large number of genes expressed in the developing heart, including XTn3.  
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Table 4.1. List of Trascripts Misregulated by Tbx20 Depletion as Assayed by 
Microarray  
Fold change for each of two independent microarrays are shown in columns two and three. 
EST nomenclature refers to my own assigned nomenclature. GenBank accession numbers are 
shown in column four. All assigned gene names and degree of similarity with known 
homologues in column five are based on annotation by the Affymetrix GeneChip. Domains 
of expression in column six were based on secondary whole-mount in situ hybridization 
screens using embryos at stages 19, 26, and 36. Highlighted genes indicate detection of 
expression in the developing heart. 
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Table 4.1. List of Trascripts Misregulated by Tbx20 Depletion as Assayed by 
Microarray 
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Table 4.2. List of Transcripts Associated with Cell Cycle Regulation Misregulated by 
Tbx5 Depletion as Assayed by Microarray  
Column one shows fold change. Column two contains GenBank accession numbers. Column 
three shows gene names and similarity with known homologues as annotated by the 
Affymettrix GeneChip. 
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Table 4.2. List of Transcripts Associated with Cell Cycle Regulation Misregulated by 
Tbx5 Depletion as Assayed by Microarray 
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CHAPTER V 
XTN3 IS A DEVELOPMENTALLY EXPRESSED CARDIAC AND SKELETAL 
MUSCLE-SPECIFIC NOVEX-3 TITIN ISOFORM3
A.  Introduction 
 The process of myogenesis in Xenopus laevis appears to be unique compared to 
mammalian and avian systems in that it is characterized by two completely distinct types of 
myogenesis (reviewed in Chanoine and Hardy, 2003).  Initially, primary myogenesis results 
in formation of uninucleate myofibers assembled during early neurula embryos that become 
functional following neurulation (stage 24).  These primary muscles are initially composed 
entirely of one “fast” fiber type, but by late tailbud stage (stage 37), a second “slow” fiber 
type appears. During metamorphosis the primary myocytes begin a wave of autonomous 
programmed cell death resulting in a complete replacement of these primary muscles with 
“adult” multinucleate muscles produced by a process of secondary myogenesis. Furthermore, 
this process has been shown to involve switching from embryonic to adult muscle protein 
isoforms by differential mRNA splicing (Hardy et al., 1999; Radice and Malacinski, 1989). 
 The giant muscle protein titin is the largest known protein in the biological world and 
the single human titin gene contains 363 exons with a coding potential of 38,138 amino 
acids. Many splice-variants of titin have been described and full-length isoforms have been 
shown to span half the sarcomere length from the Z-line to the M-line, serving to link the two 
                                                 
3 This work was originally published in Brown, D. D., Davis, A. C. and Conlon, F. L. (2006). Xtn3 is a 
developmentally expressed cardiac and skeletal muscle-specific novex-3 titin isoform. Gene Expr Patterns 6, 
913-918. 
  
regions and stabilize sarcomere length by acting as a molecular spring (reviewed in Granzier 
et al., 2002). To date, the cloning or expression of Xenopus titin orthologues has not been 
reported. Recently a novel human titin exon, termed novex-3, was identified within the 
human titin locus and shown to encode an alternative C-terminal exon resulting in a truncated 
titin isoform that is too short to reach the A-band (Bang et al., 2001).  This isoform was 
shown to be expressed in human skeletal and cardiac muscle and the protein was shown to 
bind the signaling molecule, obscurin (Bang et al., 2001). The novex-3 titin/obscurin 
complex extends in a spring-like manner when sarcomeres are stretched and has been 
hypothesized to be involved in stretch-initiated sarcomeric restructuring during muscle 
adaptation and disease (Bang et al., 2001).  This observation also lends to the possibility that 
the novex-3 titin/obscurin contributes to the development and remodeling of embryonic 
skeletal and cardiac muscles during embryonic myogenesis. Alternatively, this complex may 
be involved in the process of switching from the embryonic “fast” fiber type to the “slow” 
fiber type that occurs during late tailbud stage. 
 
B.  Materials and Methods 
DNA Constructs 
 The Xtn3 EST clone was obtained from OpenBiosystems (IMAGE ID: 5537366). The 
Xtn3-pCMV-SPORT6 plasmid was linearized using SalI and digoxigenin-conjugated in situ 
hybridization probes were synthesized using T7 polymerase.  
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Whole-mount RNA in situ Hybridization 
 Embryos were collected and fixed in MEMFA for 1.5 hours at room temperature. 
Whole-mount in situ hybridization was performed as previously described (Harland, 1991). 
Embryos were paraffin-embedded using a Tissue-Tek II Tissue Embedding Center and 
sectioned at a depth of 16 µm on a Microm HM 340 E microtome. Protein alignments were 
performed using the GeneDoc program. 
 
Reverse Transcription Polymerase Chain Reaction 
 RNA for RT-PCR was extracted from 30 st.13 embryos, 30 st.38 embryos, 500 mg 
adult heart tissue, and 500 mg adult thigh muscle tissue using the RNeasy Kit (QIAgen). 
First-strand cDNA synthesis was performed using Superscript II Kit (Invitrogen) and random 
hexamers. PCR reactions with Taq polymerase (Promega) were performed according to 
established protocol using 2 µl of the resulting cDNA. MHCα, m. actin, and EF1α primers 
sequences were obtained from the website of Eddie DeRobertis. Primers: Xtn3: forward- 
AGT TGA TAA TAC CTT CAA TGC CAC, reverse- AGA TTA TTG CAT GAA ACC 
CTG C; Tbx20: forward- GAG AAT GTT TCC TAC AAT CCG, reverse- TTC CCT CTC 
AAT ATC AGT GAG; m. actin: forward-GCT GAC AGA ATG CAG AAG, reverse-TTG 
CTT GGA GGA GTG TGT; MHCα: forward-GCC AAC GCG AAC CTC TCC AAG TTC 
CG, reverse-GGT CAC ATT TTA TTT CAT GCT GGT TAA CAG G; EF1α: forward-CAG 
ATT GGT GCT GGA TAT GC, reverse-ACT GCC TTG ATG ACT CCT AG. 
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C.  Results and Discussion 
Sequence Comparisons Between Titin Novex-3 Homologues 
 Xtn3, the partial Xenopus novex-3 titin isoform (GenBank accession: DQ241814) was 
initially identified in a screen for differentially expressed cardiac genes as an expressed-
sequence tag (EST; GenBank accession: CB564652) expressed in the developing heart. This 
EST was subsequently sequenced and a BLAST search revealed that the EST is highly 
similar to the human truncated titin isoform, novex-3 titin. The partial Xenopus novex-3 titin 
EST consists of 2771 nucleotides, encodes for 544 putative amino acids, and appears to lie 
completely within the putative novex-3 exon as identified by comparisons with human 
novex-3 titin (Fig. 5.1A). Furthermore, this EST appears to align with a single exon within 
the titin gene in the Xenopus tropicalis genome (JGI, ver. 4.1, scaffold 163). Protein 
alignments performed against a predicted chick titin (GenBank accession: XM_421979), 
predicted mouse novex-3 titin (GenBank accession: XM_619766), predicted cow novex-3 
titin (GenBank accession: XM_617216), and human novex-3 titin (GenBank accession: 
NM_133379) reveal identities in the range of 39-48% (Fig. 5.1A,B).  Furthermore, all three 
immunoglobulin cell adhesion molecule (IGcam) domains are conserved between human and 
frog, as identified by the NCBI conserved domain search (cd#: cd00931.2; Fig. 5.1A). Thus, 
the partial Xenopus titin clone is likely the Xenopus orthologue of human novex-3 titin and 
we refer to this transcript as Xtn3 for Xenopus titin novex 3.  
 
XTn3 Expression Pattern 
 Human novex-3 titin consists of 5604 amino acids and 16,812 nucleotides. Due to the 
large size of the titin gene and the many titin isoforms, it was not feasible to clone the full-
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length version of Xtn3, thus the partial Xtn3 EST was used for whole-mount in situ 
hybridization analyses. The novex-3 exon is contained only in the novex-3 titin isoform 
mRNA, thus the partial Xtn3 probe is specific for this titin isoform. Expression analyses of 
Xtn3 reveal that this transcript is initially detected during the onset of neurulation (stage 
14/15) throughout the developing presomitic mesoderm.  At this stage, Xtn3 is expressed in a 
narrow anterior domain which flares laterally toward the posterior region of the presomitic 
mesoderm (Fig. 5.2A). This pattern mirrors that of the presomitic mesoderm as it constricts 
in a wave from anterior to posterior during somite formation. By mid-neurula stage (stage 
19) Xtn3 expression becomes more restricted as the forming somites develop into vertical 
stripes (Fig. 5.2B, C). In higher magnifications of tailbud stage  embryos (stage 35) it is 
apparent that the somitic expression lies within a thin stripe down the center of the somite as 
well within a lower intensity stripe along the anterior and posterior borders of individual 
somites (inset, Fig. 5.2H). The somitic expression continues through development until 
tadpole stage at which point Xtn3 expression is almost completely undetectable (Fig. 5.2N). 
By stage 37, Xtn3 also becomes expressed in the migrating ventral myoblasts, which will 
eventually become the ventral abdominal muscles (Fig. 5.2J, L). Also at this stage Xtn3 
expression becomes apparent in the developing facial and jaw muscles (Fig. 5.2J, L). 
Expression in the migrating heart primordia was first detected prior to fusion of the primordia 
at the midline (stage 26; Fig. 5.2D, E). Cardiac expression persists throughout all stages of 
heart development until tadpole stages, at which point Xtn3 expression is almost completely 
lost (Fig. 5.2N-P). By tadpole stage (stage 46), only weak expression is detected in the jaw 
muscles. Staining of the adult heart shows very little Xtn3 expression globally. However, 
discrete groups of Xtn3-expressing cells can be detected near the surface of the myocardium 
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(Fig. 5.2O, P).  Thus, it appears that a global downregulation of Xtn3 corresponds with fully 
differentiated muscle and completion of heart development, although some expression 
remains in adult tissues. 
 Histological sectioning of embryos stained by whole-mount in situ hybridization 
revealed that Xtn3 is initially expressed more highly in the dorsal medial lip and medial 
regions of the developing myotome during neurula stage (stage 19; Fig. 5.3A). Xtn3 
expression then becomes expanded throughout the entire dorsal/ventral axis of the somitic 
domain during later stages of myotome development (Fig. 5.3A, C, E, G).  Cardiac 
expression is detected exclusively in the myocardium, consistent with the defined role of titin 
as a sarcomeric structural protein (Fig. 5.3D-H).  Xtn3 appears to be expressed in a gradient 
during looping stages of cardiogenesis, with higher levels in the ventral cardiac regions (Fig. 
5.3F, H).  Sectioning further demonstrates Xtn3 expression throughout the developing jaw 
muscles in the head (Fig. 5.3I). 
 To test whether Xtn3 transcripts are detectable in adult heart and muscle tissues, RT-
PCR was performed on RNA isolated from st.13, st.38, adult heart and adult muscle tissues. 
Xtn3 transcripts were present in st.38, adult heart and adult muscle tissues, as were transcripts 
for myosin heavy chain α (MHCα) and muscle actin.  In contrast, the heart marker Tbx20 
was only detectable in st.38 embryos and in adult heart tissue. Thus, it appears that while 
Xtn3 may be downregulated at tadpole stages as assayed by whole-mount in situ 
hybridization, Xtn3 transcripts can be detected by sensitive methods in adult muscle tissues. 
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Figure 5.1. XTN3 is a conserved titin isoform.   
(A) Schematic depicting human novex-3 titin and the partial XTN3 proteins, including 
positions of conserved Ig domains and amino acid lengths. (B) Protein alignment of Xenopus 
laevis XTN3, a predicted chick titin, a predicted mouse novex-3 titin, a predicted cow titin, 
and human novex-3 titin. Alignment was performed using the GeneDoc program. Red 
underlines indicate conserved Ig domains as identified by the NCBI conserved domain 
search. (C) Table showing degree of protein identity and similarity between the putative 
novex-3 titin orthologues.  
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Figure 5.1. XTN3 is a conserved titin isoform.   
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Figure 5.2. Xtn3 is developmentally expressed throughout the somites, heart, and jaw 
myoblasts from early neurula to late tailbud stages. 
(A-P) In situ hybridization showing expression of the Xtn3 at the indicated stages. (A-C) 
Neurula stage embryos. Anterior is to the left. (A) and (C) are dorsal views. (B) is a lateral 
view. (D-M). Tailbud stage embryos. (E,G,I,K,M). Ventral anterior views. Anterior is up. 
(H). Inset shows higher magnification of somite region. Bracket indicates one individual 
somite. (N). Tadpole stage embryo. Note the lack of staining in trunk and heart. Some light 
staining remains in facial muscles. (O, P). Adult heart lacking global Xtn3 expression. (P) is a 
magnification of (O). Black arrowhead indicates isolated group of Xtn3-expressing cells. h, 
heart; hp, heart primordia; jm, jaw myoblasts; psm, presomitic mesoderm; pc, pigment cells; 
vm, ventral myoblasts;  s, somites; t, trunk. 
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Figure 5.2. Xtn3 is developmentally expressed throughout the somites, heart, and jaw 
myoblasts from early neurula to late tailbud stages. 
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Figure 5.3. Histology of Xtn3 expression. 
Paraffin embedded embryos were sectioned at a depth of 16 µm after in situ hybridization. 
(A, C, E, G) Transverse sections through developing somites. (B, D, F, H) Transverse 
sections through developing cardiac region. (I) Transverse section showing jaw myoblasts in 
the head. a, atrium; ec, endocardium; hp, heart primordia; jm, jaw myoblasts; mc, 
myocardium; nc, notochord; nt, neural tube; s, somites; v, ventricle; vm, ventral myoblasts.  
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Figure 5.3. Histology of Xtn3 expression. 
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Figure 5.4. Xtn3 is expressed in adult heart and skeletal muscle. 
RNA from st.13 embryos, st.38 embryos, adult heart and adult muscle tissue was isolated and 
100 ng of RNA subjected to RT-PCR. Xtn3 RT-PCR shows expression in St. 38, adult heart 
and adult muscle tissues. “-RT” controls lack reverse transcriptase to show lack of genomic 
contamination. Tbx20 primers serve as controls for heart tissue, MHCα and muscle actin 
serve as controls for muscle tissue, and EF1α serves as loading control.   
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Figure 5.4. Xtn3 is expressed in adult heart and skeletal muscle. 
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CHAPTER VI 
HSP27 EXPRESSION IS DEVELOPMENTALLY REGULATED IN 
DIFFERENTIATING MUSCLE AND IS REQUIRED FOR PROPER CARDIAC 
PRECURSOR FUSION 
 
A.  Introduction 
 Of the many known congenital diseases that affect humans, those affecting 
development of the heart are among the most severe. Cardiogenesis is an incredibly complex 
process requiring the coordination of many events within well-defined spatial and temporal 
dimensions (reviewed in Harvey, 2002). The complex nature and multitude of coordinated 
steps within cardiogenesis makes this process inherently sensitive to genetic perturbation. As 
such, it is not surprising that congenital heart diseases are estimated to be present in about 
thirty percent of all infant deaths due to congenital disease (Thom et al., 2006). Furthermore, 
current data from the Centers for Disease Control estimates that one out of every one 
hundred and ten babies born in the United States is afflicted with a congenital heart disease 
(Botto et al., 2001).   
 Formation of a functioning heart requires the organization and synchronization of 
many cellular and tissue-level processes, including proper cell movements and polarity 
establishment, specification and differentiation of cardiac precursors, and morphogenesis of 
the heart. During gastrulation a bilaterally symmetric pair of fields within the anterior lateral 
  
plate mesoderm (LPM) is initially specified as cardiac precursors. Once the cardiac precursor 
fields are specified, they undergo two separate migration events as neurulation proceeds.  
The large-scale tissue movements involved in neurulation result in the anterior migration of 
the cardiac progenitors toward more anterior regions. This process seems to be largely 
controlled by FGF factors such as FGF8 and FGF4 (Beiman et al., 1996; Ciruna and Rossant, 
1999; Gisselbrecht et al., 1996; Sun et al., 1999).  Soon after migration to more anterior 
positions in the embryo, the cardiac progenitors then migrate ventrally as an epithelial sheet 
towards the anterior ventral midline where they proceed to fuse and form a linear heart tube 
(DeHaan, 1963; Kolker et al., 2000; Mohun et al., 2003).   
 Several requirements for the ventral migration and fusion of the cardiac fields have 
thus far been identified, including proper cardiomyocyte differentiation (Reiter et al., 1999; 
Yelon et al., 2000), interaction or signaling from the endoderm (Alexander et al., 1999; 
Kikuchi et al., 2000; Reiter et al., 1999; Schier et al., 1997), epithelial organization of the 
cardiac fields, and migration cues from the midline (Trinh and Stainier, 2004). Recent work 
by Trihn and Stanier has demonstrated a requirement for fibronectin (Fn) in the migrating 
cardiac precursor fields in zebrafish; fish mutant for Fn exhibit cardia bifida, which is 
characterized by unfused cardiac progenitors that independently differentiate into cardiac 
tissue (Trinh and Stainier, 2004). Their results indicate that a gradient of Fn at the junction 
between the endoderm and mesoderm appears to be required for epithelial integrity within 
the cardiac fields. Furthermore, deposition of Fn at the ventral midline appears to regulate the 
timing of migration. Other studies have shown that mutant mice lacking Fn display defects in 
cardiogenesis, despite normal specification of the cardiac precursors (George et al., 1997; 
George et al., 1993). It is also well established that the anterior endoderm is required for 
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cardiac progenitor migration (reviewed in Lough and Sugi, 2000). For example, many genes 
involved in endoderm differentiation and maturation, including Gata4, Gata5, one-eyed 
pinhead (oep), casanova, and miles apart result in cardia bifida when mutated in mice or fish 
(Kuo et al., 1997; Kupperman et al., 2000; Reiter et al., 1999; Stainier, 2001). Furthermore, 
studies have shown that abrogation of proper myocardial differentiation can also result in 
cardia bifida (Reiter et al., 1999; Yelon et al., 2000). In the present study we report an 
additional requirement for proper cardiac fusion: expression and function of the small heat 
shock protein, Hsp27. 
 Hsp27, also called Hsp25 in mice and HspB1 in humans, is one of the most widely 
distributed and most studied of the small heat shock proteins (reviewed in Ferns et al., 2006). 
Changes in Hsp27 expression have been observed in cells and tissues exposed to many stress 
conditions, including oxidative damage (Arrigo, 2001; Baek et al., 2000; Dalle-Donne et al., 
2001; Escobedo et al., 2004; Huot et al., 1996; Komatsuda et al., 1999; Mehlen et al., 1995), 
metal toxicity (Bonham et al., 2003; Leal et al., 2002; Somji et al., 1999), and ischemia 
(Hollander et al., 2004; Reynolds and Allen, 2003; Shelden et al., 2002; Vander Heide, 
2002), as well as in disease states such as cardiac hypertrophy (Knowlton et al., 1998; 
Scheler et al., 1999), and muscle myopathies (Benndorf and Welsh, 2004). In addition, a role 
for HSP27 function has been implicated in many cellular processes, including protein 
chaperone activity (Jakob et al., 1993), regulation of cellular glutathione levels  (Arrigo, 
2001; Baek et al., 2000), apoptotic signaling (Bruey et al., 2000; Paul et al., 2002), inhibition 
of actin polymerization (Benndorf et al., 1994; Miron et al., 1991; Rahman et al., 1995), and 
stabilization of actin filament arrays (Huot et al., 1996; Lavoie et al., 1993a; Lavoie et al., 
1993b; Lavoie et al., 1995).  
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 Hsp27 is known to be expressed during both skeletal and cardiac muscle development 
in several organisms, including human (Shama et al., 1999), mouse (Gernold et al., 1993), 
pig (David et al., 2000) and zebrafish (Mao et al., 2005; Mao and Shelden, 2006).  However, 
to date the biological significance of this developmentally regulated expression has not been 
analyzed in developing embryos. Furthermore, previous attempts to identify Xenopus laevis 
(X. laevis) orthologues of the Hsp27 family have reportedly failed (Norris et al., 1997). Here 
we report the sequence and expression of the X. laevis orthologue of heat shock protein 27 
(XHsp27).  We demonstrate using anti-sense morpholinos that XHSP27 is required for proper 
fusion of cardiac precursors and for actin organization in developing cardiac and skeletal 
muscle. We further demonstrate that cardiac specification and differentiation appear 
unaltered as assayed by several markers of cardiac precursor and differentiated 
cardiomyocyte populations.  
 
B.  Materials and Methods 
Embryo Culture and Injections 
 Preparation and injection of X. laevis embryos was carried out as previously 
described (Wilson and Hemmati-Brivanlou, 1995). Embryos were staged according to 
Nieuwkoop and Faber (Nieuwkoop and Faber, 1967). An antisense morpholino 
oligonucleotide was designed against the translation start site of XHsp27. XHSP27 
morpholinos were obtained from Gene Tools, LLC. with the following sequence: 5’  AAT 
TCT GCG TTC TGA CAT TTT CTC T 3’. The human β-globin splice-mutant standard 
control morpholino from Gene Tools was used as control. For the in vitro translation studies, 
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TBX20MO was used to show specificity of the HSP27MO (Brown et al., 2005). HSP27MO 
was injected at 60 ng/embryo. 
 
Translation Inhibition by Morpholinos 
 In vitro translations were performed using TNT Coupled Reticulocyte Lysate System 
(Promega) following the manufacturer’s protocol. Reactions were carried out in the presence 
or absence of HSP27MO or TBX20MO. A carboxy-terminal hemagluttin tagged version of 
HSP27 was generated using the pSP64T-HA vector (generous gift of Masazuma Tada). An 
HA-tagged TBX20 was also used in the in vitro translation study (Brown et al., 2005). We 
have recently demonstrated that X. laevis SHP2 is uniformly expressed throughout early 
development (Brown et al., 2005) and anti-PTP1D/SHP2 primary antibody was used at 
1:2500 (Transduction Laboratories) as a loading control with peroxidase-conjugated 
AffiniPure donkey anti-mouse (H+L) 2° antibody (1:10,000). HA-tagged proteins were 
probed with anti-HA primary antibody (Covance) at 1:1000 dilution, and peroxidase-
conjugated AffiniPure Donkey anti-mouse (H+L) secondary antibody (Jackson 
ImmunoResearch Laboratories) at 1:10,000 dilution. For in vivo translation analyses, 
embryos were injected with MOs and mRNA at the one-cell stage. At stage 19, 40 embryos 
per treatment were collected and lysed in 300 µl of lysis buffer: 140 mM NaCl, 50 mM Tris 
(pH 7.6), 10 mM EDTA, 1% Surfact-Amps Triton-100 (Pierce), Complete EDTA-free 
Protease Inhibitor (Roche), and 25mM PMSF (Roche). Lysates were resolved on 12% SDS-
PAGE gels, and visualization was carried out using luminol-based chemi-luminescence 
solutions at 1:1 ratio: solution A: 100 mM Tris pH8.5, 2.5 mM Luminol (Sigma), 0.4 mM p-
Coumaric acid (Sigma); solution B: 100 mM Tris pH 8.5, 0.02% H2O2 (Sigma). 
 118
Whole-mount RNA in situ Hybridization 
 Whole-mount in situ hybridization was performed as previously described (Harland, 
1991). Probes used include Tbx20 (Brown et al., 2003), Nkx2.5 (Brown et al., 2005), Gata4 
and Gata6 (generous gifts of Roger Patient; (Jiang and Evans, 1996), Mlc1v’ (IMAGE clone 
4408657, GenBank Accession No.: BG884964), and Titin Novex 3 (Brown et al., 2006). 
 
Immunohistochemistry 
 Embryos were prepared for whole-mount immunohistochemistry as previously 
described (Kolker et al., 2000). Briefly, fixed embryos were incubated overnight at 4°C with 
an antibody against myosin heavy chain α (Abcam), at a dilution of 1:500. Following washes, 
the embryos were incubated overnight at 4°C with a Cy3-conjugated anti-mouse secondary 
antibody (Sigma) at a dilution of 1:100. For imaging, embryos were cleared with 2:1 benzyl 
benzoate: benzyl alcohol and viewed on a Leica MZFLIII fluorescence dissecting 
microscope. For immunostaining of histological sections, embryos were collected at the 
indicated stages, fixed for 2 hours in 4% paraformaldehyde, and embedded in OCT 
cryosectioning medium (Tissue Tek). Cryostat sections (14 µm) were rinsed with wash 
buffer (PBS with 1% Triton and 1% heat inactivated calf serum), and incubated at 4°C 
overnight, as indicated, with mouse anti-myosin heavy chain α (Abcam), at a dilution of 
1:500 or anti-tropomyosin 1:50 (Developmental Studies Hybridoma Bank), and phalloidin 
conjugated to Alexa 488 flourophore (Molecular Probes). Sections were then rinsed with 
wash buffer and incubated with anti-mouse Cy3-conjugated secondary antibody (1:200; 
Sigma). Sections were rinsed and incubated for 20 minutes at room temperature with DAPI, 
cover slipped and visualized on a Zeiss LSM410 confocal microscope.  
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Transmission Electron Microscopy 
 Briefly, stage 37 embryos were fixed in 2% paraformaldehyde/2.5% gluteraldehyde 
overnight (Goetz et al., 2006). Embryos were post-fixed in ferrocyanide-reduced osmium and 
embedded in Spurr’s epoxy resin. Transverse ultra-thin (70 nm) sections were mounted on 
copper grids, and post-stained with 4% aqueous uranyl acetate followed by Reynolds’ lead 
citrate. Sections were imaged with a LEO EM-910 transmission electron microscope. 
 
C.  Results 
XHsp27 Expression is Developmentally Regulated in Differentiating Cardiac and 
Skeletal Muscle. 
 XHsp27, the X. laevis orthologue of Hsp27 (HSP25, HspB1; GenBank Accession 
No.: EF066483) was initially identified in a screen for differentially expressed cardiac genes 
as an expressed sequence tag (GenBank Accession No.: AW766262) expressed in the 
developing heart (D. Brown and F.L.C., unpublished data). This EST was subsequently 
sequenced and a BLASTn search revealed that the EST is highly similar to several members 
of the small heat shock protein 27 subfamily. The X. laevis Hsp27 transcript consists of at 
least 1123 nucleotides and encodes for 213 putative amino acids (Fig. 6.1A). The XHsp27 
transcript appears to align with a single locus within the Xenopus tropicalis (X. tropicalis) 
genome (JGI, ver. 4.1, scaffold 72), consisting of 3 exons separated by two introns. This 
organization appears to mirror that of mouse Hsp27 (Ferns et al., 2006), which also consists 
of three exons. In addition, a synteny search using Metazome (www.metazome.net) reveals 
that the genomic locus within X. tropicalis is highly syntenic with the Hsp27 orthologue 
locus on human chromosome 7, mouse chromosome 5, rat chromosome 12, and chick 
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chromosome 19. (Fig. 6.1C). Protein alignments performed against Hsp27 orthologues in 
human (GenBank Accession No.: BC073768), rat (GenBank Accession No.: NM_031970), 
mouse (GenBank Accession No.: AK003119), pig (GenBank Accession No.: 
NM_001007518), dog (GenBank Accession No.: NM_001003295), chick (GenBank 
Accession No.: NM_205290), and zebrafish (GenBank Accession No.: NM_001008615) 
reveal conservation of identities in the range of 64-70% (Fig. 6.1A-B). An “alpha-crystallin-
hsps” domain within the transcript is conserved between the Hsp27 orthologues, as identified 
by the NCBI conserved domain search (cd#: cd00298; Fig. 6.1A). The crystallin domain is 
known to be important in homo- and heterodimerization between various sHSPs (Feil et al., 
2001). Furthermore, one of two putative actin interacting domains appears to be highly 
conserved between XHsp27 and the various orthologues, with a second domain showing a 
smaller degree of conservation (Fig 6.1A; Mao et al., 2005). Thus, this transcript is likely the 
X. laevis orthologue of Hsp27 and we refer to this transcript as XHsp27. 
 By whole-mount in situ hybridization, XHsp27 appears to be expressed diffusely 
throughout the developing embryo during gastrulation, consistent with recent findings in 
zebrafish (Fig. 6.2; Mao and Shelden, 2006).  Shortly after gastrulation XHsp27 becomes 
restricted to thin dorsal-ventral stripes within a subdomain of each developing myotome 
within the somitic mesoderm (Fig. 6.2A).  This expression initially begins in the anterior 
most somites and proceeds in a wave towards the posterior end, mirroring the wave of 
somitic formation and development (Fig 6.2B-L). As myogenesis progresses, the thickness of 
each vertical stripe expands to encompass the entire myotome and this expression remains in 
the developing muscle until at least stage 40 (Fig 6.2B-I).  During cardiac precursor fusion 
and linear heart tube formation, XHsp27 expression commences throughout the developing 
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myocardium and remains expressed throughout the developing heart at all stages examined 
(Fig 6.2G-I, L, M).  Furthermore, as muscle development continues during early tadpole 
stages, XHsp27 expression becomes evident in other muscle domains such as those in the 
developing jaw and the body wall (Fig 6.2I). Expression is also detected in the brain of 
tadpole stage embryos (Fig 6.2I). These results indicate that XHsp27 is a developmentally 
regulated gene and may be involved in gastrulation, cardiac and skeletal myogenesis, and 
neural development. 
 
XHSP27 Morpholinos Specifically Inhibit XHSP27 Translation 
 In order to test whether XHsp27 protein is required during embryogenesis, we sought 
to knock down endogenous XHSP27 protein levels using antisense morpholino 
oligonucleotides. To this end we designed morpholinos targeted against the start site of 
XHsp27, which we refer to as HSP27MO (Fig. 6.3A).  Unfortunately, attempts to detect 
endogenous or in vitro translated X. laevis HSP27 were unsuccessful using several of the 
available commercial HSP27 antibodies.  Thus we sought to test the efficiency and 
specificity of morpholino translation inhibition using a hemagglutinin (HA) epitope-tagged 
version of XHSP27 both in vitro and in vivo. For the in vitro inhibition study, 
transcription/translation reactions were incubated with HA-HSP27 construct alone and 
together with increasing concentrations of HSP27MO (Fig. 6.3B). TBX20MO was included 
as a negative control (Brown et al., 2005). Furthermore, HSP27MO was incubated with HA-
Tbx20 to show specificity of the HSP27MO. Results from these assays show that HSP27MO 
efficiently blocks translation of HA-XHsp27 in vitro while TBX20MO and ControlMO do 
not. In contrast, HSP27MO does not block translation of HA-TBX20 (Fig. 6.3B). 
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 In order to test whether HSP27MO can knock down XHSP27 translation in vivo, HA-
Hsp27 capped mRNA was injected into one-cell stage embryos along with HSP27MO.  To 
insure that the MOs did not bind the mRNA prior to injection, embryos were first injected 
with 30 ng or 60 ng HSP27MO or 60 ng ControlMO. Embryos were then re-injected with 
100pg HA-HSP27 capped mRNA prior to first cleavage. Embryos were then collected at 
stage 20, lysed, submitted to Western blotting with an anti-HA antibody. An antibody against 
the protein phosphatases, SHP2, was used as loading control (Brown et al., 2005). As shown 
in Figure 6.3C, embryos injected with HSP27MO completely lack HA-HSP27 protein, in 
contrast to ControlMO injected embryos, which display no inhibition of HA-HSP27 
translation. 
 
XHSP27 misexpression results in gastrulation defects and can be partially rescued by 
XHSP27 morpholinos 
 As described above, we sought to test morpholino efficiency by coinjecting 
morpholinos and capped HA-XHsp27 capped mRNA into one-cell stage embryos.  
Surprisingly, injection of 1ng HA-XHsp27 resulted in dramatic gastrulation defects 
characteristic of exogastrulation, which is a failure of blastopore closure (Fig. 6.4A). Hsp27 
is known to regulate actin filament polymerization and stability, suggesting that the failure of 
blastopore closure may be due to defects in actin dynamics (reviewed in Mounier and Arrigo, 
2002). The fact that XHsp27 is normally expressed diffusely in gastrulating embryos, 
combined with the observation that misexpression of XHsp27 results in gastrulation defects, 
suggest that regulation of XHsp27 expression or activity is necessary for proper gastrulation.  
Furthermore, embryos co-injected with HA-XHsp27 mRNA and HSP27MO displayed a 
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partial rescue of the gastrulation phenotype (Fig. 6.4B, C). Injection of HA-XHsp27 alone 
results in 99.5% exogastrulation. However, embryos co-injected with 60 ng HSP27MO 
display exogastrulation 66% of the time, and the gastrulation defects appear less severe (Fig. 
6.4). These results suggest that the gastrulation defects are a specific effect of HA-XHsp27 
misexpression and that HSP27MO can inhibit translation of the injected HA-XHsp27 mRNA.  
 
The Cardiac Transcriptional Program Appears to be Unaltered in XHSP27 Morphants. 
 To assess whether the cardiac and skeletal muscle precursors are properly specified 
and differentiate, embryos were injected with HSP27MO or ControlMO at the one-cell stage. 
Whole-mount in situ hybridizations were then performed using a panel of cardiac and 
skeletal muscle markers. Tbx20, Nkx2.5, Gata4, and Gata6 probes were used to mark both 
early cardiac precursors and terminally differentiated cardiomyocytes, while titin novex-3 
(XTn3) and myosin light chain 1v’ (Mlc1v’) were used to mark differentiated skeletal and 
cardiac muscle.  As shown in Figure 6.5, the cardiac and skeletal muscle domains appeared 
normal in all cases. This data, combined with the observation that the hearts are contractile, 
suggests that the cardiac and skeletal muscle precursors are properly specified, migrate to the 
correct location within the embryo and can initiate terminal differentiation.  
 
Knockdown of XHSP27 Protein Translation Results in Cardia Bifida. 
 To determine the requirement for XHSP27 during development, we again injected 
HSP27MO into one-cell stage embryos. Despite XHsp27 expression in gastrula embryos, no 
defects in gastrulation were observed, suggesting that XHSP27 is not required for this 
process. However, by linear heart tube formation stage (stage 33), defects in heart tube fusion 
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became apparent as assayed by myosin heavy chain (MHC) whole-mount antibody staining 
(Fig. 6.6J-L).  As shown in Figure 6.4, XHSP27 morphants display a bifurcation in the 
posterior inflow region of the linear heart tube. The degree of bifurcation varies between 
embryos, and in the most severe cases the hearts appear to be almost entirely divided, 
resulting in complete cardia bifida (Fig. 6.6P-R). Despite aberrant morphogenesis of the 
heart, the extant cardiac tissue becomes rhythmically contractile, although blood flow is not 
evident in these embryos (data not shown). This data suggests that the cardiomyocytes 
differentiate, but the cardiovascular system is not functional.  Furthermore, XHSP27 
morphant embryos arrest development by early tadpole stages (stage 40) and die shortly 
thereafter, presumably due to the lack of a functioning cardiovascular system.  These results 
suggest that XHSP27 is critical for proper cardiac morphogenesis. 
 
XHSP27 Morphants Display Actin Filament Disorganization in the Developing Heart 
and Somites. 
 Recent studies have shown that in addition to a requirement for cardiac differentiation 
and endoderm maturation in heart tube formation, proper epithelial organization, adhesion 
and migration are absolutely critical for heart tube formation. Furthermore, HSP27 has been 
shown to stabilize the actin cytoskeleton in response to stress (Huot et al., 1996; Lavoie et al., 
1993a; Lavoie et al., 1993b; Lavoie et al., 1995). Thus considering that the cardiomyocytes 
are apparently specified and differentiate properly, XHsp27 is not detected in endoderm 
tissue, and XHsp27 is known to be involved in cytoskeletal dynamics, we hypothesized that 
actin organization may be disrupted in the developing myotomes and heart of XHSP27 
morphants.  To address this possibility we injected HSP27MO into one-cell stage embryos 
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and collected the embryos at stages during cardiac fusion (stage 28), linear heart tube 
formation (stage 33), and cardiac looping (stage 37).  Embryos were then transversely 
cryosectioned and cardiac sections were immunostained for myosin heavy chain α (MHC) 
using a MHC-specific antibody and F-actin using phalloidin. Somitic sections were stained 
for F-actin and with DAPI to mark nuclei in somitic sections.  In control hearts, actin staining 
is most apparent at the basal and apical surfaces of the cells in the forming heart tube, which 
consists of a single layer of cardiac cells, as well as in fibers perpendicular to the lumen, 
which appear to correspond with the lateral membranes of cardiac cells (Fig. 6.7A-C, G-I).  
However, in XHSP27 morphant hearts, actin staining appears diffuse and disorganized (Fig. 
6.7D-F, J-L). Few distinct fibers are apparent within the morphant hearts, except where 
lumen formation occurs (Fig. 6.7L). A similar and more dramatic defect in actin organization 
is evident within the developing somites.  In control morpholino-injected embryos, the 
somites display thick, highly organized actin bundles oriented along the anterior-posterior 
axis (Fig. 6.7M-O, S-U).  However, in XHSP27 morphants, the actin appears disorganized 
and scattered throughout the somites (Fig. 6.7P-R, V-X).  Furthermore, the somitic domain 
itself appears to be larger and less well-defined (Fig. 6.7P-R, V-X).  This appearance is 
similar to the appearance of the somites at earlier stages, after which the somites normally 
become smaller and more compact, possibly due to the formation of the thick actin bundles. 
These results suggest that XHsp27 is required for proper regulation of cytoskeletal dynamics 
during myogenesis. 
 In order to gain further insight into the nature of microfilament disorganization in 
XHSP27 morphants, embryos were injected with control or XHSP27 morpholinos, collected 
at stage 38 and visualized using transmission electron microscopy (TEM). As shown in 
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Figure 6.8, ControlMO hearts display many myofibril bundles, the majority of which were 
found to be oriented along the anterior-posterior axis, as demonstrated by transversely 
sectioned myofibers (Fig. 6.8-C). In regions where longitudinal sections of myofibers are 
present, clear z-lines are evident showing the fusion between individual sarcomeres (Fig. 
6.8A, B). Furthermore, in transverse myofiber sections, the highly organized myosin 
structure can be seen (Fig. 6.8C inset). In contrast, XHSP27 morphant hearts show very few 
myofiber structures (Fig. 6.8D-E). In addition, the occasional myofibers are very short and 
no z-lines or connections between multiple fibers were apparent, indicating a lack of 
sarcomeric assembly (Fig. 6.8D-E). In some sections, large aggregates of bodies are apparent 
that appear very similar to cross-sectional views of myosin in control myofibrils (Fig. 6.8F 
inset). However, these aggregates lack any of the obvious structure in spacing or organization 
characteristic of myofibrils (Fig. 6.8F inset). Similar results are observed within the 
developing myotomes in the somitic region of XHSP27 morphants. In the forming skeletal 
muscle, all myofibers analyzed appeared to be sectioned transversely, indicating that these 
fibers are arranged along the anterior-posterior axis. ControlMO-injected myotomes display 
thick myofiber structures that generally extend throughout the entire cell (Fig. 7G, H). In 
higher magnifications, the myofibril structure is visible as highly ordered arrays of 
microfilaments (Fig. 7H). In contrast, XHSP27 morphants display much fewer apparent 
myofibers and most of these appear abnormal in morphology (Fig. 7I, J). Magnification of 
these myofibers reveal a less-ordered structure and an apparent lack of thick myosin 
filaments in these structures (Fig. 7J). These observations suggest that the lack in actin 
organization is accompanied by a failure of myofibril assembly and sarcomere formation. 
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D.  Discussion 
Developmental Regulation of Hsp27 Expression 
 Hsp27 has been shown to be involved in a diverse array of cellular processes.  In 
general, the majority of functional data on Hsp27 comes from experiments performed both in 
vitro and in cell culture, and much of this research has focused on the function of Hsp27 in 
response to various cellular stressors.  However, surprisingly little has been done to address 
the potential role of Hsp27 in developing embryos.  In this study, we report the identification 
of X. laevis Hsp27 and demonstrate that this orthologue is expressed in a developmentally 
regulated manner throughout developing gastrula, skeletal muscle and cardiac tissues.  The 
temporal and spatial expression appears to be highly conserved between X. laevis and 
zebrafish (Mao and Shelden, 2006).  As in the fish, XHsp27 is initially detected diffusely 
throughout the gastrulating embryo, suggesting that Hsp27 may be involved in gastrulation.  
However, embryos depleted of XHsp27 protein by antisense morpholinos did not display any 
defects in gastrulation, suggesting either that XHSP27 is not required for gastrulation or that 
a functionally redundant sHSP is present in X. laevis. During neurulation, XHsp27 expression 
commences in the anterior most developing somites, followed by a posterior wave of 
expression in newly forming somites. As development proceeds, expression within the 
somitic myotomes expands to encompass the entire myotome, suggesting that XHSP27 may 
be involved in morphogenesis or differentiation of muscle tissue. However, our data from 
XHSP27-depleted embryos suggest that XHSP27 functions in cytoskeletal dynamics but is 
not involved in differentiation. In addition to its role in skeletal muscle, XHsp27 is expressed 
in developing cardiac tissue, beginning at heart tube formation, with this expression 
continuing through stage 40. During tadpole stages, additional domains of expression within 
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developing jaw and body wall muscles also become evident, suggesting that XHSP27 may be 
involved in general mechanisms of muscle formation and development. 
 
Hsp27 in gastrulation  
 As in the fish, Hsp27 is initially detected diffusely throughout the gastrulating 
embryo, suggesting that Hsp27 may be involved in gastrulation.  Surprisingly, embryos 
depleted of Hsp27 protein by antisense morpholinos did not display any defects in 
gastrulation.  There are several reasons as to why this might be the case. It may be that Hsp27 
is simply not required for gastrulation per se. However, Hsp27 is known to be a primary 
protective agent in response to stress, thus expression during gastrulation may serve as 
insurance against stressors during this brief but critical moment in development. It is also 
possible that functional redundancy between other sHSPs in the gastrulating embryo might 
compensate for the loss of Hsp27.  In support of this hypothesis, bovine Hsp20, a related 
sHSP member, has been shown to bind actin, similar to turkey Hsp27, suggesting a possible 
similarity in function (Brophy et al., 1999; Miron et al., 1988). Furthermore, Hsp27 has been 
found by yeast 2-hybrid studies to bind several sHSPs, including Hsp20, Hsp22 and αB-
crystallin (Benndorf et al., 2001; Liu and Welsh, 1999). However, Hsp20 and Hsp22 have 
yet to be described in Xenopus, and αB-crystallin is not known to be expressed in muscle 
tissues.  It will be interesting to learn whether other sHSP members are also involved in 
embryogenesis. It is also formally possible that our Hsp27 morpholino does not eliminate all 
HSP27 protein, allowing enough to be translated to perform its function during gastrulation.  
This seems unlikely considering the fact that the morpholinos efficiently induce muscular 
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and cardiac phenotypes at much later stages after the morpholino is significantly diluted in 
the embryo.  
 Even more interesting is the finding that misexpression of an epitope-tagged Hsp27 
results in severe defects in blastopore closure. Hsp27 has been shown to be an effective 
inhibitor of actin polymerization in vitro, and many studies have implicated Hsp27 in actin 
cytoskeletal dynamics (reviewed in (Mounier and Arrigo, 2002). In addition, studies have 
shown that a dominant-negative form of Xenopus Ral, a downstream effector of the Ras 
pathway, results in actin disorganization leading to failure of blastopore closure (Lebreton et 
al., 2003). Thus, it is possible that an alteration of actin organization due to overexpression of 
Hsp27 is the primary cause of the failure of blastopore closure. In support of this hypothesis 
are the findings that dominant-negative Hsp27 results in aberrant microfilament morphology 
and defects in endothelial cell motility and that Hsp27 regulates fibroblast adhesion, 
migration, and matrix contraction during wound healing (Hirano et al., 2004; Piotrowicz et 
al., 1998). 
 
Hsp27 in Cardiogenesis and Myogenesis 
 Formation of a linear heart tube requires the coordination of cardiac specification, 
differentiation, and cell behavior within defined spatial and temporal domains. In the present 
study, we identify the small heat shock protein, Hsp27, as being integral to this process. 
Several studies have shown that Hsp27 is expressed in developing muscle tissues.  While it is 
clear that Hsp27 is critical in mediating the cellular response to a wide variety of stressors, it 
is unclear what role Hsp27 may be playing during cardiogenesis and myogenesis under un-
stressed physiological conditions. Evidence from studies of embryonic stem cell 
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differentiation has suggested that Hsp27 can function as a molecular switch between 
differentiation and apoptosis (Mehlen et al., 1997). Furthermore, it is known that proper 
cardiomyocyte differentiation is necessary for cardiac fusion and heart tube formation (Reiter 
et al., 1999; Yelon et al., 2000). However, while our data does not rule this out as a possible 
function for XHsp27, it at least suggests that a primary function of Hsp27 may be to regulate 
actin dynamics in the context of myogenesis.  Our results show that the cardiac and skeletal 
muscle appears to be specified and to differentiate normally, at least as assayed by several 
markers of specification and terminal myocyte differentiation. Furthermore, the total amount 
of cardiac and skeletal tissue appears grossly normal in XHsp27-depleted embryos. With the 
exception of actin, all markers examined appear to be normally expressed and the defects in 
heart development appear to be primarily morphogenetic in nature. These data suggest that 
the cause of the cardiac defect is not a failure of cardiomyocyte differentiation. It remains 
formally possible that the cardiac fusion defects may result from a loss of differentiation or 
an increase in apoptosis in a subset of cardiac precursors at the midline, essentially creating a 
barrier between the two cardiac fields. However, further studies must be conducted to 
precisely define whether Hsp27 can influence differentiation or apoptosis in the developing 
embryo. 
 Abrogation of XHsp27 function in X. laevis embryos results in improper fusion of the 
cardiac progenitors, resulting in two unfused or partially fused contractile hearts. Our data 
suggest that the primary role of Hsp27 in cardiogenesis is to regulate actin dynamics, and 
thus cell motility or adhesion. In support of this hypothesis, previous research has shown that 
cardiac epithelial integrity and cell motility and adhesion are critical for proper fusion of the 
cardiac primordia (Trinh and Stainier, 2004). In addition, the precardiac field was shown to 
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consist of a single polarized epithelial layer. Our results demonstrate that actin fibers are 
visible primarily at the cell membrane in the single-cell layered cardiac precursors. However, 
in XHSP27-depleted embryos, few discreet fibers are visible. These results suggest that 
epithelial organization or polarization is defective in the cardiac fields and that XHSP27 is 
required for this organization. Actin fiber organization appears to be morphologically 
different in developing skeletal muscle. Within the developing myotomes, thick actin fibers 
are arranged in an anterior-posterior orientation and do not appear to delineate the 
membranes in an epithelial manner. However, similar to what is seen in cardiac primordia, 
actin protein appears to be completely disorganized in XHSP27 morphant embryos, again 
suggesting that cell polarity or tissue integrity is affected by HSP27 loss.  
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Figure 6.1. XHsp27 is a conserved member of the Hsp27 subfamily of proteins. 
(A) Protein sequence alignments of X. laevis Hsp27 with various Hsp27 orthologues. 
Alignment was performed using the GeneDoc program. Blue underline indicates conserved 
crystallin domain. Red underline indicates putative actin interacting domains. (B) Percent 
identity and similarity between Hsp27 orthologues. (C) Synteny between X. tropicalis, 
human, mouse, rat, and chick Hsp27 loci as revealed by Metazome. Hsp27 is indicated in 
black. Upstream and downstream genes are colored as indicated. 
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Figure 6.1. XHsp27 is a conserved member of the Hsp27 subfamily of proteins. 
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Figure 6.2. XHsp27 is expressed in the gastrula, and developing skeletal and cardiac 
muscle 
Whole mount in situ hybridization of X. laevis embryos using an antisense probe specific for 
XHsp27 at the indicated stages. (A) Dorsal is to the top. (B-I) Anterior is to the left. b, body 
muscle; br, brain; h, heart; j, jaw muscle, m, myotome. 
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Figure 6.2. XHsp27 is expressed in the gastrula, and developing skeletal and cardiac 
muscle 
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Figure 6.3. HSP27 morpholinos specifically block translation in vitro. 
(A) Diagram depicting XHsp27 mRNA structure and morpholino-targeted region. (B) 
Western blot demonstrating translation inhibition in vitro using rabbit reticulocyte lysate. 
Reactions were incubated with the indicated amounts of HA-Hsp27 mRNA and/or 
HSP27MO. TBX20MO was included as a negative control. HSP27MO was incubated with 
HA-Tbx20 mRNA to show specificity of the HSP27MO. HA-HSP27 and HA-TBX20 was 
visualized using anti-HA antibody, and SHP2 antibody was used as loading control. (C) 
Western blot demonstrating translation inhibition in vivo by coinjection of HA-Hsp27 mRNA 
with HSP27MO. Embryos were injected with the indicated amount of HSP27MO, 
ControlMO, and/or HA-Hsp27 mRNA. Embryos were collected at stage 20. Western blotting 
was performed on lysate using anti-HA antibody. SHP2 antibody was used as loading 
control. 
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Figure 6.3. HSP27 morpholinos specifically block translation in vitro. 
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Figure 6.4. XHSP27 misexpression results in gastrulation defects and can be partially 
rescued by XHSP27 morpholinos. 
Embryos were injected with 1 ng HA-XHsp27 mRNA (A-C) and co-injected with either 30 
ng HSP27MO (B) or 60 ng HSP27MO (C). Wild-type embryos are shown as a control (D). 
Numbers at the bottom show the percent of embryos displaying exogastrulation and the total 
number of embryos assayed per treatment.  All embryos shown are displayed with anterior to 
the left and posterior to the right. 
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Figure 6.4. XHSP27 misexpression results in gastrulation defects and can be partially 
rescued by XHSP27 morpholinos. 
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Figure 6.5. Specification and differentiation of cardiac and skeletal muscle appear 
unaltered in HSP27 morphants. 
Whole-mount in situ hybridizations using antisense probes against (A) Nkx2.5, (B) Tbx20, 
(C) Gata4, (D) Gata6, (E) Mlc1v’, and (F) Titin novex 3 (Tn3). Embryos were injected with 
either HSP27MO or ControlMO and fixed at the indicated stages. (A-F) Ventral views with 
anterior upward. (E, F) Stage 37 embryos shown laterally with anterior to the left. All 
markers analyzed appear normal between control and HSP27 morphant embryos. 
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Figure 6.5. Specification and differentiation of cardiac and skeletal muscle appear 
unaltered in HSP27 morphants. 
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 Figure 6.6. Depletion of XHSP27 results in unfused or partially fused hearts. 
Whole-mount antibody staining using anti-myosin heavy chain α (MHC). Embryos were 
injected at the one-cell stage with either HSP27MO or ControlMO, fixed, and stained for 
MHC at the indicated stages. All views are ventral with anterior upwards. Arrows indicate 
separation between the two cardiac fields or developing hearts. a, atrium; i, inflow tract; o, 
outflow tract; v, ventricle. 
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Figure 6.6. Depletion of XHSP27 results in unfused or partially fused hearts. 
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Figure 6.7. Depletion of XHSP27 results in actin disorganization in developing skeletal 
and cardiac muscle. 
Transverse 12 µm sections through the heart (A-L) and somite (M-X). All sections are shown 
with dorsal upward. Heart sections were immunostained for F-actin using phalloidin (A, D, 
G, J) and MHC using anti-MHC antibody (B, E, H, K). Overlays are shown in (C, F, I, L). 
Somite sections were immunostained for F-actin using phalloidin (M, P, S, V) and stained 
with DAPI to visualize the nuclei (N, Q, T, W). Overlays are shown in (O, R, U, X). 
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Figure 6.7. Depletion of XHSP27 results in actin disorganization in developing skeletal 
and cardiac muscle. 
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Figure 6.8. XHSP27 morphant ultrastructure analysis reveals a lack in myofibril 
assembly. 
Transmission electron microscopy of ventral myocardium in stage 38 control and XHSP27 
morphant hearts. (A-C) Ventral myocardium of ControlMO injected embryo. (D-F) Ventral 
myocardium of XHSP27MO injected embryo. Inset in (C) shows magnification of myofibril 
structure and inset in (F) shows magnification of apparent myosin aggregates. Scale bars 
depicts 2µm distance. l, longitudinal myofibers section; t, transverse myofibers section; z, z-
line. (G, H) Muscle fibers within the myotome in stage 38 control morpholino injected 
embryos. (I, J) Muscle fibers within the myotome in stage 38 XHsp27 morpholino injected 
embryos. l, longitudinal myofibers section; t, transverse myofibers section; z, z-line. 
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Figure 6.8. XHSP27 morphant ultrastructure analysis reveals a lack in myofibril 
assembly. 
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CHAPTER VII 
GENERAL DISCUSSION 
 
 The development of a functional multi-chambered contractile heart from a simple 
patterned tube involves a number of interacting transcriptional networks acting within well-
defined temporal and spatial parameters.  While many of the regulatory transcription factors 
have been identified and shown to be required for proper cardiogenesis, much remains to be 
deciphered regarding how these pathways interact at different times and within different cell 
populations during cardiogenesis.  In addition, very little is currently known as to the specific 
downstream pathways affected by the various transcriptional regulators known to be 
involved in cardiac morphogenesis. Thus, one of the main challenges within the field of heart 
development is to not only identify the transcriptional regulators involved in cardiogenesis, 
but to also place these factors within specific pathways and cellular contexts and to 
understand how these pathways interconnect to direct the precise morphogenetic changes 
required for heart formation. 
  
A.  The Role of Tbx20 in Cardiogenesis 
  Many studies on various T-box genes have shown this family of transcription factors 
to be integral to numerous developmental processes during embryogenesis (reviewed in 
Naiche et al., 2005; Showell et al., 2004). Prior to the work included herein, previous studies 
had indicated that several vertebrate homologues of Tbx20 are expressed at the proper time 
  
and place to potentially regulate cardiogenesis (Ahn et al., 2000; Griffin et al., 2000; Iio et 
al., 2001; Kraus et al., 2001; Meins et al., 2000). These data, combined with the observation 
that Tbx20 is likely ancient in evolutionary origin, existing as far back as invertebrates 
(Brook and Cohen, 1996b), suggest that Tbx20 likely plays a critical role in embryogenesis, 
particularly within heart development. In this work I demonstrate the identification of the X. 
laevis orthologue of Tbx20 and demonstrate high homology to other vertebrate orthologues 
of Tbx20 in both sequence and expression (Chapter II; Brown et al., 2003). I further 
demonstrate that removal of Tbx20 from the amphibian heart results in a dramatic decrease in 
cardiac cell numbers and a complete lack of looping morphogenesis (Chapter III; Brown et 
al., 2005). These findings are corroborated by findings in both mouse and zebrafish which 
display nearly identical phenotypes upon removal of functional Tbx20 (Cai et al., 2005; 
Singh et al., 2005; Stennard et al., 2005; Szeto et al., 2002; Takeuchi et al., 2005). A 
somewhat surprising finding among all of these studies is the observation that cardiac 
specification and development in Tbx20-depleted embryos appears to be completely normal 
until formation of a linear heart tube. Experiments from my work and others have shown that 
Tbx20 is expressed in the cardiac precursor fields within the lateral plate mesoderm at very 
early stages prior to ventral migration of the precursors (Chapter II, Ahn et al., 2000; Brown 
et al., 2003; Carson et al., 2000; Griffin et al., 2000; Iio et al., 2001; Kraus et al., 2001; Meins 
et al., 2000). Despite this early expression, the specification, migration, and differentiation of 
the cardiac progenitors appears to be normal in Tbx20-depleted embryos as assayed by 
several cardiac markers, including Nkx2.5, ANF, and TnIc (Chapter III; Brown et al., 2005). 
Thus, it remains to be determined whether Tbx20 plays a role within the cardiac progenitors 
during these early time periods. One possible explanation for this finding is the possibility 
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that removal of Tbx20 results in subtle changes within the cell that only become apparent 
during heart tube formation and morphogenesis. These changes may be in the proliferative 
capacity of the cardiac progenitors, such that early Tbx20 expression is required to initiate 
events that eventually lead to proliferation during cardiac morphogenesis. Alternatively, it 
may be that other transcription factors can function in place of TBX20 upon its removal. 
Evidence from mice indicates that removal of TBX20 results in misexpression of a related T-
box gene, Tbx2, throughout the Tbx20 expression domain in both early cardiac progenitors 
and the later heart tube (Cai et al., 2005; Singh et al., 2005; Stennard et al., 2005). Both of 
these transcription factors have been show to be repressive in activity (Cai et al., 2005; 
Carreira et al., 1998; Plageman and Yutzey, 2004). It is thus possible that TBX2 may be able 
to bind targets of TBX20, thus taking over the repressive role of TBX20 on these targets. 
However, if this is indeed the case, it appears that TBX2 expression cannot compensate for 
the loss of TBX20 during later cardiac morphogenesis, as the heart is severely abnormal in 
the absence of TBX20. One way to test this hypothesis involves the co-injection of 
morpholinos against Tbx20 and Tbx2 to determine if removal of both proteins can result in 
earlier cardiac phenotypes. It is also formally possible that TBX5 may be functionally 
redundant with TBX20 during early cardiac progenitor development; however two lines of 
evidence suggest that this is not likely. Studies have indicated that TBX20 primarily acts as a 
transcriptional repressor, in contrast to TBX5 which is known to activate target genes (Cai et 
al., 2005; Ghosh et al., 2001; Plageman and Yutzey, 2004). Furthermore, Tbx5 and Tbx20 do 
not share fully overlapping domains of expression; for example, Tbx5 is not expressed in the 
future outflow region, which is a domain of very high Tbx20 expression (Ahn et al., 2000; 
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Brown et al., 2003; Chapman et al., 1996b; Iio et al., 2001; Kraus et al., 2001; Meins et al., 
2000). Thus, it seems unlikely that TBX5 can function in place of TBX20. 
 My own studies on embryos lacking TBX20 or TBX5 indicate that morphant hearts 
show significant decreases in numbers of cells within the heart (Chapter III; Brown et al., 
2005). Furthermore, work in collaboration with Sarah Goetz has indicated that in the case of 
Tbx5, it appears that a primary defect of TBX5 depletion is a delay or halt in cell cycle 
progression (Goetz et al., 2006).  In addition, studies of Tbx20-null mice indicate that TBX20 
depletion leads to repression of Nmyc1, a cell cycle regulator, via deregulation of Tbx2 
expression (Cai et al., 2005). Taken together these results suggest that a primary role of 
TBX20 during cardiac morphogenesis is to regulate cardiomyocyte proliferation which leads 
to the patterned growth required for proper looping and morphogenesis. However, there is 
one inconsistency in the results showing Tbx2 de-repression in mice (Cai et al., 2005). In this 
study, the authors propose a model whereby TBX2 normally represses Nmyc1 and thus 
proliferation in the developing outflow tract, while TBX20 represses Tbx2 in chamber 
myocardium resulting in higher proliferation rates. However, they fail to note that the 
outflow tract is one of the regions in which Tbx20 is very highly expressed. Thus, by this 
model TBX20 should repress Tbx2 expression in the outflow region. To the contrary, both 
factors are found to be highly expressed within this region (Ahn et al., 2000; Brown et al., 
2003; Carreira et al., 1998; Iio et al., 2001; Kraus et al., 2001; Meins et al., 2000). Thus it 
appears that the relative functions of these factors in cardiogenesis are more complex and 
will be likely found to be highly context dependent, being affected by the presence of 
numerous other transcription factors and perhaps post-translational modifications depending 
on the specific cell type. This is evidenced by findings from my work and others 
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demonstrating that TBX20 can physically and functionally interact with several other factors, 
including TBX5, NKX2.5, GATA4, and GATA5, which can in turn interact with each other 
(Brown et al., 2005; Stennard et al., 2003). These studies have shown that the specific 
interactions between various transcription factors can lead to either synergistic activation or 
repression of target promoters, depending on which factors are present and which promoter is 
being assayed. The above findings highlight the apparent complexity of interconnectedness 
between the various transcriptional networks within developing cardiac tissue and pose 
significant challenges for future studies on cardiogenesis.  
 The major findings that will likely help in elucidating this incredibly complex 
network of pathways, will be the identification of targets of these factors’ transcriptional 
activity. While studies have succeeded in identifying targets for individual transcription 
factors, such as connexin40 and atrial natriuretic factor (ANF) for TBX5, very little is 
known as to the biological significance of binding to these targets (Bruneau et al., 2001; 
Hiroi et al., 2001). More importantly, even less is known about the effects of the various 
putative complexes containing multiple cardiac transcription factors on target regulation. 
However, a leap forward in this understanding will likely come with the advent of the 
bourgeoning techniques of performing large scale chromatin immunoprecipitation (ChIP) 
and microarray-based chromatin immunoprecipitation (ChIP-on-chip) screens (reviewed in 
Buck and Lieb, 2004; Hanlon and Lieb, 2004). Using ChIP-on-chip, researchers can 
immunoprecipitate a transcription factor, pulling along any genomic fragments to which the 
factor is bound, and hybridize the genomic fragments to a microarray, thus learning which 
sequences within the genome are being regulated by the particular transcription factor. 
However, this technique relies heavily on two major requirements: a highly-specific antibody 
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and a well annotated complete genome sequence. With the completion of the Xenopus 
tropicalis genome, this technique may well provide many new insights into cardiogenesis 
and biology in general. However, in the case of T-box genes, very few antibodies have been 
found that will bind the T-box proteins efficiently and specifically. Thus, antibody 
development will remain a large challenge for T-box research and cardiogenesis research in 
the future. 
 
B.  Transcriptional Activity of Tbx20 
 One of the main challenges for understanding the role of Tbx20 during cardiogenesis 
remains the elucidation of the specific transcriptional activity of Tbx20 on endogenous 
promoters.  Current evidence from our work and others indicates that the precise 
transcriptional activity appears to be highly context dependent, with Tbx20 activating 
transcription in some cases while repressing it in others. Much of the work analyzing Tbx20 
transcriptional activity has relied on use of the ANF promoter. In the present study, we have 
shown that TBX20 can activate transcription of the ANF promoter to an even greater degree 
than TBX5, although total activation is low for both factors (Chapter III; Brown et al., 2005). 
Similar results were obtained by two other reports in which the authors reported low 
activation by TBX20 of either the ANF or connexin 40 promoters or a minimal promoter 
containing multiple tandem NKX2.5 binding elements (Plageman and Yutzey, 2004; 
Stennard et al., 2003). We have further demonstrated that at low doses, TBX20 can 
synergistically activate transcription with TBX5 on the ANF promoter, while at higher doses 
it can repress activation by TBX5 (Chapter III; Brown et al., 2005). In contrast, Takeuchi and 
colleagues (2003) have demonstrated that TBX20 has no effect on transcription by TBX5 on 
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the ANF promoter, while inhibiting synergistic activation by TBX5 and GATA4 together or 
TBX5 and NKX2.5 together (Takeuchi et al., 2003). Similarly, Plageman and Yutzey (2004) 
have demonstrated that co-expression of Tbx20 with Tbx5 can result in repression of 
activation on the ANF promoter by TBX5. However, in this study the presence of TBX20 
had no effect on activation by NKX2.5 or GATA4 (Plageman and Yutzey, 2004).  
 The specific activity of TBX20 has become further complicated by the identification 
of additional Tbx20 isoforms that lack the carboxy-terminal domains, which are presumably 
the domains necessary for transcriptional activity (Stennard et al., 2003). In this study, the 
long form of Tbx20, Tbx20a, which contains the entire carboxy terminus, was shown to elicit 
low levels of transcriptional activity on the ANF promoter (Stennard et al., 2003). This same 
isoform was shown to synergistically activate transcription by NKX2.5 and GATA4 on the 
ANF and connexin40 promoters, while the isoform of Tbx20 lacking the carboxy terminus, 
Tbx20c, was shown to increase transcription by NXK2.5 and GATA4 to an even greater 
extent (Stennard et al., 2003). Their study thus suggests that TBX20 can synergistically 
activate transcription with NKX2.5 and GATA4, in contrast to the study by Plageman and 
Yutzey, demonstrating no synergistic activity (Plageman and Yutzey, 2004; Stennard et al., 
2003). The above experiments were all performed using reporter constructs driven by 
promoters not known to be direct targets of TBX20 transcriptional activity, such as the ANF 
and connexin40 promoters. Furthermore, DNA binding assays have shown that TBX20 can 
only weakly bind a modified consensus T-box binding element within the ANF promoter 
(Stennard et al., 2003). Thus, a major determinant in our understanding of the in vivo activity 
and binding potential of TBX20 must come with the identification of direct targets of TBX20 
function. 
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 Recent evidence from mice lacking Tbx20 has demonstrated that a primary defect of 
TBX20 depletion is a direct loss of repression of Tbx2 within the heart (Cai et al., 2005; 
Singh et al., 2005; Stennard et al., 2005). Furthermore, TBX20 has been show to directly 
bind to and repress transcription of the Tbx2 promoter (Cai et al., 2005). Thus, it appears that 
in some contexts TBX20 can activate transcription by itself, repress transcription by TBX5, 
synergistically activate transcription by NKX2.5 and GATA4, or repress transcription of 
Tbx2. It remains to be determined which, if any, of these activities occur within the 
embryonic heart and on which targets this activity occurs, with the exception of Tbx2 
repression, which appears to be a bona fide function of TBX20.  
 
C.  Tbx20 and Human Disease 
 As described in Chapter I, two members of the T-box gene family have been 
implicated in human congenital heart disease, with Tbx5 mutations being associated with the 
autosomal dominant Holt-Oram Syndrome (Basson et al., 1997; Li et al., 1997) and Tbx1 
deletion frequently associated with DiGeorge Syndrome (Merscher et al., 2001; Yagi et al., 
2003). Mutation of another T-box family member, Tbx3 has been shown to cause human 
autosomal dominant Ulnar-Mammary Syndrome, a disease characterized by upper limb 
defects, mammary hypoplasia and genital abnormalities (Bamshad et al., 1997). The defects 
associated with all three disorders appear to arise due to haploinsufficiency of the respective 
T-box genes. Consistent with this hypothesis, patients with Holt-Oram Syndrome or Ulnar-
Mammary Syndrome are typically heterozygous for Tbx5 and Tbx3, respectively, and Tbx1 
heterozygous mice phenotypically recapitulate DiGeorge Syndrome (Bamshad et al., 1997; 
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Basson et al., 1997; Li et al., 1997; Lindsey et al., 2001). These observations suggest that 
cardiac morphogenesis and embryogenesis are sensitive to T-box gene dosage.   
 Mice heterozygous for Tbx5 recapitulate the Holt-Oram Syndrome abnormalities, 
displaying atrial and septal defects as well as upper limb abnormalities (Bruneau et al., 
2001).  Furthermore, mice completely lacking Tbx5 show more severe phenotypes 
characterized by hypoplastic, unlooped, and non-functional hearts (Bruneau et al., 2001). 
This finding is further supported by my own work which demonstrates a nearly identical 
cardiac phenotype in X. laevis embryos depleted of TBX5 protein using antisense 
morpholinos (Chapter III; Brown et al., 2005). These results suggest that in addition to 
mutations in Tbx5 that can cause a survivable cardiac abnormality, mutation of both Tbx5 
alleles may be responsible for some pregnancies that fail to come to term.  
 At the present time, no inheritable cardiac disorders have been mapped to the locus of 
Tbx20, chromosome 7p14. However, given that studies have shown that precise Tbx5 gene 
dosage is critical in proper cardiac and limb development, combined with work by myself 
and others demonstrating a requirement for Tbx20 in cardiogenesis, it remains possible that 
human congenital heart defects may arise from mutation of Tbx20. It is further possible that 
mutation of only one allele of Tbx20 may be sufficient to prevent proper cardiogenesis and 
thus preclude a pregnancy from coming to term. One possible outcome of Tbx20 mutation 
may lie in the development of neurological disorders. As described in Chapter II, Tbx20 is 
expressed within rhombomeres in the hindbrain that contribute to motor development and 
function (Brown et al., 2003). Furthermore, as mentioned in Chapter III, depletion of TBX20 
using antisense morpholinos results in a complete lack of motor function in X. laevis 
embryos. These results suggest that Tbx20 may play a role in neuronal development.  
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 Recently, studies have mapped a subset of human congenital neuropathies to the 
locus of Tbx20 in humans, namely chromosome 7p14 (Ellsworth et al., 1999). Charcot-
Marie-Tooth (CMT) disease is a progressive neuropathy of the peripheral nervous system, 
and is the single most-common inherited neuropathy at an estimated prevalence of 1 in 2,500 
(Skre, 1974). The non-demyelinated forms of CMT are denoted “CMT2” and four subclasses 
of this disease have been found mapping to four distinct loci. One such subclass, CMT2D, 
has been demonstrated to map to a region of chromosome 7p14, the same region containing 
Tbx20 (Ellsworth et al., 1999). It is thus tempting to hypothesize that mutation of Tbx20 may 
be involved in the development of CMT2D. Of further interest is the fact that, as mentioned 
in Chapter VI, a separate subclass of CMT2 has been demonstrated to arise from mutations 
within the Hsp27 gene in a separate locus on chromosome 7 (Evgrafov et al., 2004). I 
initially identified Hsp27 in X. laevis due to its’ apparent misregulation in response to loss of 
TBX20 as assayed by microarray analysis. Although it remains to be determined whether 
Hsp27 is truly downstream of TBX20 function and whether CMT2D can result from Tbx20 
mutation, these apparent connections suggest that this is indeed a possibility. 
 TBX20 may also be a candidate for contributing to retinal diseases. Work by myself 
and others have demonstrated that Tbx20 is expressed in the developing eye (Chapter II; 
Brown et al., 2003; Carson et al., 2000; Kraus et al., 2001; Meins et al., 2000). Furthermore, 
misexpression of Tbx20 in X. laevis results in defects in eye development (Carson et al., 
2004). Consistent with these observations, two inherited eye disorders have been found to 
map to loci on chromosome 7 in regions encompassing the Tbx20 locus, with retinitis 
pigmentosa (RP9) having been mapped to chromosome 7p13-15 (Inglehearn et al., 1994) and 
blepharophlemosis syndrome (BPES) having been mapped to chromosome 7p13-21 (Maw et 
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al., 1996). However, the potential role of Tbx20 in BPES has been brought into question by a 
recent study by Meins and colleagues (2000) demonstrating that BPES may map to a locus 
16 cM distal to Tbx20 (Meins et al., 2000). In addition, the study failed to detect mutations 
within Tbx20 exons 3, 4, or 5 in a patient with RP9 (Meins et al., 2000). Despite these 
findings, it remains formally possible that mutation in other regions of Tbx20 or in regulatory 
elements of Tbx20 may be causative in RP9. 
 
D. HSP27, Cardiogenesis, and Myogenesis 
 In Chapter VI, I describe the identification of the X. laevis orthologue of the small 
heat shock protein Hsp27 and demonstrate that this orthologue is expressed in a 
developmentally regulated manner throughout developing skeletal and cardiac muscle 
tissues. I further demonstrate that Hsp27 function is essential for cardiac precursor fusion and 
actin organization. As described in Chapter I, formation of a linear heart tube requires the 
coordination of cardiac specification, differentiation, and cell behavior within defined spatial 
and temporal domains. Furthermore, fusion of the cardiac progenitors to create a single heart 
tube requires the coordination of many processes, including proper cardiomyocyte 
differentiation (Reiter et al., 1999; Yelon et al., 2000), signaling from the endoderm 
(Alexander et al., 1999; Kikuchi et al., 2000; Reiter et al., 1999; Schier et al., 1997), 
epithelial organization of the cardiac fields, and migration cues from the midline (Trinh and 
Stainier, 2004). In the present study, I identify the small heat shock protein, Hsp27, as being 
integral to this process. While it is clear that Hsp27 is critical in mediating the cellular 
response to a wide variety of stressors, it is unclear what role Hsp27 may be playing during 
cardiogenesis and myogenesis under unstressed physiological conditions. While 
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cardiomyocyte differentiation is known to be required for proper cardiac fusion (Reiter et al., 
1999; Yelon et al., 2000), and Hsp27 is known to affect differentiation in some contexts 
(Mehlen et al., 1997), my data suggest that Hsp27 is dispensable for differentiation within 
developing cardiac and skeletal muscle precursors. It appears instead that HSP27 is necessary 
for initiating or maintaining actin cytoskeleton organization, as loss of HSP27 results in 
dramatically disorganized actin networks. In support of these findings, previous research has 
shown that cardiac epithelial integrity and cell motility and adhesion are critical for proper 
fusion of the cardiac primordia (Trinh and Stainier, 2004). Our results demonstrate that actin 
fibers are visible primarily at the cell membrane in the single-cell layered cardiac precursors. 
However, few discreet fibers are visible in HSP27-depleted embryos. These findings suggest 
that epithelial organization or polarization is defective in the cardiac fields. An even more 
dramatic actin network disorganization is apparent in the developing myotomes of HSP27 
morphant embryos. Within the developing myotomes, thick actin fibers are arranged in an 
anterior-posterior orientation. However, similar to what is seen in cardiac primordia, actin 
protein appears to be completely disorganized in HSP27 morphant embryos. Thus I have 
demonstrated that HSP27 is critical in regulating actin networks in developing muscle tissue 
and that proper actin organization is required for cardiac fusion. 
 
E. Conclusions 
 The work included herein represents a contribution to our understanding of the factors 
and mechanisms involved in the formation of the vertebrate heart. Prior to my studies, the 
function and requirement of the T-box gene, Tbx20, in cardiogenesis was completely 
unknown, and the X. laevis orthologue of Tbx20 had not been previously identified. By 
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isolating and characterizing the sequence and expression of X. laevis Tbx20, I have shown 
this gene to be very highly conserved throughout evolution, indicating a likely critical 
function of this gene in heart development (Chapter II; Brown et al., 2003). Through a series 
of experiments, primarily utilizing protein depletion approaches, I have demonstrated that 
Tbx20 function is critical in the developing organism for controlling morphogenetic 
processes that result in proper cardiac formation (Chapter III; Brown et al., 2005). I have 
further shown that at least one role of Tbx20 is to coordinately regulate cardiogenesis along 
with Tbx5 (Chapter III; Brown et al., 2005). As mentioned in Chapter I, a main challenge 
within the field of cardiogenesis is to decipher not only what factors are involved in 
cardiogenesis, but how these different factors within different molecular pathways coalesce 
in different cell types and contexts to regulate the complex changes involved in heart 
formation. By demonstrating a physical and functional interaction between TBX20 and 
TBX5 I have identified one step at which multiple pathways may converge to modulate 
transcription of genes involved in cardiogenesis (Chapter III; Brown et al., 2005). Findings 
from a microarray-based screen I conducted to identify genes downstream of TBX5 function 
resulted in the identification of several cell cycle genes putatively misregulated in response to 
loss of Tbx5 (Chapter IV). This observation has directly led to a study conducted by Sarah 
Goetz in which she demonstrated a requirement for Tbx5 for proper cell cycle progression, 
thus further elucidating downstream pathways in heart development (Goetz et al., 2006). A 
similar screen I performed to identify genes misregulated in response to loss of TBX20 has 
yielded the identification of many previously uncharacterized genes expressed within the 
developing heart, indicating a potential role for these genes in controlling cardiogenesis and 
setting up the basis for many future studies to come (Chapter IV). Furthermore, I have 
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characterized the expression of two of these genes during cardiac and skeletal muscle 
development, titin novex 3 (XTn3; Chapter V), and heat shock protein 27 (XHsp27; Chapter 
VI). By eliminating XHSP27 protein in the embryo I have further shown that this gene is 
critical for fusion of cardiac precursors and proper organization of actin filament networks, 
thus furthering our understanding of small heat shock proteins in embryonic development 
(Chapter VI). Thus, this dissertation work represents a significant advance in our 
understanding of cardiogenesis at multiple levels, including the identification of factors 
involved in cardiogenesis, interactions between these factors, and downstream cellular 
behaviors affected by these factors.  
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